Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2023 Dec 27;19(12):e1011899. doi: 10.1371/journal.ppat.1011899

Malaria parasite centrins can assemble by Ca2+-inducible condensation

Yannik Voß 1,2, Severina Klaus 1,3, Nicolas P Lichti 1, Markus Ganter 1, Julien Guizetti 1,*
Editor: Dominique Soldati-Favre4
PMCID: PMC10775985  PMID: 38150475

Abstract

Centrins are small calcium-binding proteins that have a variety of roles and are universally associated with eukaryotic centrosomes. Rapid proliferation of the malaria-causing parasite Plasmodium falciparum in the human blood depends on a particularly divergent and acentriolar centrosome, which incorporates several essential centrins. Their precise mode of action, however, remains unclear. In this study calcium-inducible liquid-liquid phase separation is revealed as an evolutionarily conserved principle of assembly for multiple centrins from P. falciparum and other species. Furthermore, the disordered N-terminus and calcium-binding motifs are defined as essential features for reversible biomolecular condensation, and we demonstrate that certain centrins can form co-condensates. In vivo analysis using live cell STED microscopy shows liquid-like dynamics of centrosomal centrin. Additionally, implementation of an inducible protein overexpression system reveals concentration-dependent formation of extra-centrosomal centrin assemblies with condensate-like properties. The timing of foci formation and dissolution suggests that centrin assembly is regulated. This study thereby provides a new model for centrin accumulation at eukaryotic centrosomes.

Author summary

Malaria occurs when a small parasite, named Plasmodium falciparum, invades our red blood cells where it grows and multiplies. Parasite multiplication requires segregation of the replicated genetic material into multiple new nuclei, which are then packaged into multiple new daughter cells at once. This process is coordinated by a small cellular structure called centrosome. The centrosome of malaria parasites remains poorly characterized, but centrin proteins are one of the few conserved components. In this study we investigate the properties of centrins that were thought to assemble by polymerization. We, however, discovered that centrins can assemble by so-called liquid-liquid phase separation. Phase separation can be conceptualized like oil droplets floating on a soup, but in a biological context the droplets are highly concentrated in a specific protein while the surroundings are largely depleted. We uncover that specific structural features and calcium binding are required for centrins to rapidly undergo phase separation. To investigate centrin behavior in vivo we developed a novel expression system to modulate protein concentration, which is a critical feature of phase separation. Our study provides a new model of how centrins might accumulate at the centrosome and reveals a previously unknown property of this highly conserved protein family.

Introduction

Malaria-causing parasites are divergent unicellular eukaryotes and still cause the death of over 600.000 people per year [1]. To proliferate in the red blood cells of their human host, they use an unconventional cell division mode called schizogony [26]. It involves multiple asynchronous rounds of closed mitosis followed by a final round of parasite budding, releasing 12–30 daughter cells from the bursting host cell [7] (Fig 1A). The high number of progeny promotes rapid proliferation and is therefore directly linked to disease severity [8]. Nuclear multiplication requires formation and duplication of the parasite microtubule organizing center (MTOC), also called centriolar plaque, which substantially differs from the highly structured spindle pole body of yeast and the centriole-containing mammalian centrosome [9,10]. Centriolar plaques consist of an amorphous chromatin-free intranuclear compartment from where all mitotic spindles originate, which connects through the nuclear envelope to a protein dense extranuclear compartment, where centrins localize [1115]. Centrins have various proposed functions and are one of the most widely conserved component of eukaryotic MTOCs [9,1618]. In yeast, they localize to the half-bridge of spindle pole bodies, where they are required for duplication [19]. In mammalian cells, centrins are found inside the centrioles and are implicated in the function of centrosomes [2023]. How such a small and well-conserved structural protein functions within those divergent sub-cellular contexts is still unclear. Centrins contain four EF-hand (EFh) domains that can chelate calcium with high affinity, causing conformational changes [24,25]. Calcium-dependent self-interaction of centrins has been documented in a range of eukaryotes including for human centrin 2 (HsCen2) [24,2629], although the nature of this interaction is unknown. While yeasts encode one centrin, humans have three centrins but only HsCen2 and 3 are directly associated with the centrosome in all tissues [21,30]. The centrin protein family in Plasmodium spp. has expanded to four members (Fig 1B), of which three are essential in the blood stage of infection [13,14,31,32]. While the C-terminal sequence containing the EFh domains is homologous, their N-terminus is more variable and can contain phosphorylation sites [3336]. Centrin relocalization from the cytoplasm to the centriolar plaque at the onset of schizogony has been suggested [1214]. Which mechanisms drive centrin accumulation in the context of divergent eukaryotic centrosomes is unclear. Here we use biochemical assays with recombinant centrins to reveal their assembly by calcium-dependent liquid-liquid phase separation in vitro. A combination of live cell and super resolution imaging with a novel inducible overexpression system in P. falciparum blood stage parasites reveals the conditions required for centrin condensate formation in vivo.

Fig 1. PfCen1-4 localize to centriolar plaque and can display liquid-like dynamics.

Fig 1

(A) Schematic of nuclear and cell division during asexual blood stage schizogony (B) Schematic of PfCen1-4 and HsCen2 indicating reported post-translational modifications and EFh domains. (C) Immunofluorescence staining of tubulin and PfCen1-4-GFP in parasite strains. All images are maximum intensity projections (MIP). DNA stained with Hoechst. Scale bars; confocal, 1 μm, STED, 100 nm. (D-E) STED time lapse of centriolar plaque region of parasites expressing PfCen1-Halo labeled with MaP-SiR-Halo dye. DNA stained with SPY505-DNA. Scale bar, 100 nm. Quantification of ratio (black line) between height and width (grey lines) of the PfCen1-Halo signal, as indicated in the small schematic.

Results

All P. falciparum centrins localize to the centriolar plaque where they undergo dynamic rearrangement

To assess the localization of PfCen1-4, we episomally expressed GFP-tagged proteins (S1 Fig) in cultured P. falciparum blood stage parasites. Previous studies have suggested that P. berghei centrins1-3 are refractory to endogenous tagging at the C- and N-terminus [13] and our experience confirms that tagging of the C-terminus of PfCen1 and 3 is not achievable even using small tags (see also Materials and Methods). Episomally expressed PfCen1-4-GFP localized to the centriolar plaque during schizogony (Fig 1C), and Stimulated Emission Depletion (STED) microscopy showed heterogenous shapes of the fluorescent signal. To address whether this heterogeneity might be the result of a dynamic reorganization of centrin within this diffraction-limited region, we implemented live cell STED using a parasite line expressing PfCen1 tagged with Halo (S1 Fig) and labeled with the MaP-SiR-Halo fluorogenic dye [37] (Fig 1D–1E). This either revealed ‘wobbling’ droplet-like shapes (Fig 1D, S1 Movie), or structures that stretched and retracted along a defined axis (Fig 1E, S2 Movie). These dynamics were reminiscent of biomolecular condensates [38], concentrated protein droplets that form by liquid-liquid phase separation (LLPS), which has emerged as a biological principle explaining the formation of membrane-less organelles, including centrosomes [39].

P. falciparum and human centrins can undergo calcium-dependent liquid-liquid phase separation

To test whether centrins can phase-separate, we expressed 6His-tagged PfCen1-4 and HsCen2 in E. coli (S2 Fig) and imaged concentrated recombinant protein solutions. After addition of calcium, we observed rapid droplet formation for PfCen1, PfCen3, and HsCen2 (Fig 2A, S3S5 Movies). The droplets fused and showed surface wetting, both hallmarks of LLPS [40]. Addition of EDTA led to instant dissolution of the droplets, except for PfCen3 where non-coalescing droplets remained (Fig 2A, S6 Movie), which can be interpreted as a condensate maturation process towards a more solid or gel-like state [41]. To quantify centrin phase separation kinetics, we measured the turbidity of the solutions by light scattering (Fig 2B). Upon calcium addition, we observed a rapid increase in turbidity that was caused by protein droplet formation (S3A Fig) in PfCen1, PfCen3, and HsCen2 solutions (Fig 2B). Addition of Mg2+ as an alternative bivalent cation did not cause a reaction in PfCen1 and only a very reduced one for PfCen3 and HsCen2, suggesting that the effect was calcium-specific (S3B Fig). By exploring a range of PfCen1 concentrations we identified the critical saturation concentration, csat, i.e., the concentration threshold at which a protein transitions from a one-phase to a two-phase regime, to be around 10–15 μM for the different centrins (S3C Fig), which is within the range of what can be found for in vitro phase separation of other proteins (bio-comp.org.cn/llpsdb) [42]. GFP-tagging of PfCen1 did not disrupt LLPS (S3D Fig), which suggests that this property can be preserved in parasite lines episomally expressing tagged PfCen1 (Fig 1B–1D). To exclude the possibility that the 6His-tag influences phase separation we repeated our analysis with an untagged version of recombinant centrins (S2C Fig), which revealed that PfCen1 and 3 can still phase separate, while PfCen2 and 4 failed to do so even at very high concentrations (S3E Fig). Since PfCen3 condensation was not completely reversible, we added EDTA at earlier timepoints and found that the irreversible fraction increased over time (S4A Fig). This is compatible with the lack of observable fusion events at later time points after calcium addition (S4 Movie), again suggesting a maturation of the condensate [41]. To further test if PfCen3 assembly occurs via LLPS we imaged droplet formation at a lower temperature, which slowed maturation and we detected more fusion events (S7 Movie). In contrast, maturation in PfCen1 condensates was not observed as they could still be fully disassembled by addition of EDTA 3 hours after induction (S4B Fig). Taken together this demonstrates that centrins have differential capacities to undergo calcium-inducible LLPS.

Fig 2. PfCen1, 3 and HsCen2 undergo calcium-dependent and reversible LLPS in vitro.

Fig 2

(A) Widefield image of highly concentrated recombinant centrin solutions to promote high droplet density of PfCen1-6His (200 μM), PfCen2-6His (120 μM), PfCen3-6His (193 μM), PfCen4-6His (120 μM), HsCen2 (200 μM) before, after 2 mM CaCl2 addition, and after 10 mM EDTA addition. Scale bars, 10 μm. Inlays show time lapse images of droplet fusion events. Movie metadata was used to estimate the time after calcium addition (bottom) (B) Turbidity measurements in centrin solutions at 30 μM (and higher concentration where indicated) during calcium addition followed by EDTA. Conditions: 50 mM BisTris (pH 7.1) at 37°C.

Intrinsic disorder in the N-terminal sequence of centrins predicts self-assembly

A common feature of phase-separating proteins are intrinsically disordered regions (IDRs) [38], which we analyzed for the different centrins. Indeed, the prediction tool IUPred3 showed high IDR probabilities within the N-termini of PfCen1, PfCen3, and HsCen2, but not for PfCen2 and PfCen4 (S5A Fig). Hence, presence of a N-terminal IDR predicts LLPS for centrins in the tested cases. Analysis for IDRs using IUPred3 in centrins from a range of eukaryotes suggests that most of those species encode at least one IDR-containing centrin (S5B Fig). For some centrins from distant eukaryotes, ‘polymer-like’ behavior was previously noted in vitro, suggesting that LLPS might be an evolutionary conserved feature of a subset of centrins [2628]. To further test this hypothesis, we selected IDR-containing centrins from three evolutionarily distant unicellular eukaryotes i.e., Trypanosoma brucei (TbCenA), Chlamydomonas reinhardtii (CrCen) and Saccharomyces cerevisiae (ScCdc31) for recombinant expression (S2C Fig). They showed increases in turbidity upon calcium addition, although Cdc31 required a higher protein concentration (Fig 3A). This may be related to the comparatively lower predicted intrinsic disorder of its protein sequence (Fig 3B). Microscopic analysis confirmed that in vitro all three centrins form fusogenic droplets that display surface wetting and dissolve upon EDTA addition (Fig 3C, S8S10 Movies), which indicates that LLPS likely is a conserved feature for multiple centrins.

Fig 3. Centrins from highly divergent eukaryotes can undergo phase separation in vitro.

Fig 3

(A) Turbidity measurements of recombinant T. brucei centrin A (TbCenA, 196 aa), C. reinhardtii centrin (CrCen, 169 aa) and S. cerevisiae centrin (Cdc31, 161 aa) at 30 μM (and higher concentrations where indicated) during calcium addition to 2 mM followed by 10 mM EDTA. Conditions: 50 mM BisTris (pH 7.1) at 37°C. (B) Using the IUpred 3.0 prediction we find a correlation between intrinsic disorder region probability (red line) and LLPS in vitro. (C) Widefield images of recombinant centrin solutions of TbCenA (100 μM), ScCdc31 (200 μM), CrCen (100 μM) after 2 mM CaCl2 addition show droplets and surface wetting, which dissolves quickly after addition of 10 mM EDTA. Scale bar, 10 μm.

Phase-separating centrins can form co-condensates in vitro

Interactions between centrins in malaria parasites have already been demonstrated [13,43] and are supported by our localization data (Fig 1C). To test whether different centrins could phase separate together, we determined the saturation concentration csat for PfCen1 and 3. Under the conditions presented here, we found csat to be around 10 μM for both and detected no LLPS even when increasing molecular crowding by adding 20 μM of BSA (Fig 4A and 4B). When, however, replacing BSA with the other centrin, we observed clear LLPS at the same total protein concentration indicating that PfCen1 and 3 promote each other’s condensation (Fig 4C). This effect is likely due to co-condensation into joint PfCen1-PfCen3 droplets, as shown by incorporation of PfCen1-GFP into preformed PfCen3 droplets (Fig 4D). To test whether PfCen2 and PfCen4 might synergistically contribute to centrin co-condensation we measured turbidity for several combinations (S6 Fig). Consistent with their inability to form condensates on their own PfCen2 did not further contribute to condensation while PfCen4 might have a slight inhibitory effect.

Fig 4. PfCen1 and PfCen3 interact through co-condensation.

Fig 4

(A-C) Turbidity measurements of recombinant PfCen1-6His and PfCen3-6His at individually subcritical concentrations either independently or as a mixture during addition of calcium followed by EDTA. Individual centrins were supplemented with BSA to a consistent total protein concentration of >20 μM. (D) Brightfield and fluorescence imaging of preformed 30 μM PfCen3-6His protein droplets in presence of Ca2+ before and 30 s after addition of recombinant PfCen1-GFP-6His at 30 μM. Focus was adjusted between timepoints. Scale bar, 10 μm. All conditions: 50 mM BisTris (pH 7.1) at 37°C.

Centrin overexpression causes premature formation of in vivo assemblies with condensate-like properties

While live cell STED microscopy hinted at liquid-like dynamics (Fig 1D–1E), we next investigated whether condensation of centrins can occur in vivo by overexpressing centrins. Since phase separation is concentration-dependent, we speculated whether this would induce additional formation of condensates in parasites. To exert better control over the expression levels of PfCen1-GFP than with the classical overexpression vector (S1 and S7A Figs), we designed a novel P. Falciparum Inducible Overexpression (pFIO) plasmid to be transfected in a DiCre recombinase expressing acceptor strain (Fig 5A). Upon addition of rapamycin the dimerized recombinase excises the first open reading frame, placing the gene of interest immediately downstream of the promoter. We designed a version with the medium strength hsp70 promoter fragment (pFIO) and the stronger hsp86 promoter (pFIO+), for which we confirmed a substantial increase in median expression levels upon induction (S7B Fig), while some parasites remained GFP-negative. To estimate the degree of overexpression achieved by pFIO+-Cen1-GFP we quantified the ratio between PfCen1-GFP and endogenous PfCen1 at around 18:1 by Western blot using an anti-PfCen1 antibody, while correcting for the fraction of GFP-negative cells (S8 Fig). In cells displaying those high overexpression levels, we frequently observed accumulations of PfCen1-GFP signal that were not associated with any spindle structure or the nucleus. Those Extra-Centrosomal Centrin Accumulations (ECCAs) occurred in 56% (n = 54) of cells carrying the medium strength promoter (Fig 5B) and in 97% (n = 60) of cells with the strong promoter (Fig 5C). ECCAs are not observed in wild type cells when labeling endogenous centrin [12,44]. When quantifying PfCen1-GFP fluorescence intensity within a cell population carrying the same plasmid the number of ECCAs correlated positively with total cell fluorescence intensity, despite the reduced range of observed signal intensities (S9 Fig). When reevaluating our earlier data from the weaker expressing pARL-Cen1/3-GFP parasite lines, we could occasionally detect ECCAs, although their frequency was too low for systematic quantification. When measuring the dimensions of the centrin signal at the centriolar plaque we found that upon pFIO+-Cen1-GFP overexpression the width (321 vs 324 nm) was unchanged, while the height (219 vs 247 nm) showed an increase of 11% (S10 Fig). To test if overexpression of PfCen1-GFP affects the dynamics of centrin assembly, we used time-lapse microscopy. Initially, cells showed a homogenous cytoplasmic distribution, while ECCAs frequently assembled before the formation of the first mitotic spindle (Fig 5D, S11 Movie). Centrin accumulation by biomolecular condensation predicts that once a critical concentration threshold is crossed, additional centrin would only accrue into the condensate fraction. Machine-learning-based image analysis showed that PfCen1-GFP concentration in the cytoplasm remained stable, while the fraction of PfCen1-GFP in foci increased once their formation started (Fig 5E). The partition coefficient of centrin signal between cytoplasmic and foci fraction was stable around 4.0 until it slightly increased to 5.3 after mitotic spindle formation (S11 Fig). At the end of schizogony, centrin foci disappeared, while the total centrin signal stayed constant, which indicates that centrin assemblies are dissolved (Fig 5E). Usually centrin localizes to the centriolar plaque at the onset of schizogony as marked by the formation of the first mitotic spindle [12]. To further test if overexpression of PfCen1-GFP affects the dynamics of centrin assembly, we quantified the first appearance of ECCAs relative to mitotic spindle formation (Fig 5F). Indeed, PfCen1-GFP coalesces into ECCAs and at the centriolar plaque prematurely but not earlier than a few hours before the entry into the schizont stage. The timing of both ECCA and centriolar plaque foci formation was, however, concentration-dependent, which can best be explained reaching the critical concentration for schizogony-associated condensation earlier [12]. ECCAs often formed first at the centriolar plaque before detaching, which further suggests an involvement of schizogony-specific nucleation factors (S12 Movie). To test if ECCAs and centrosomal centrin foci contain protein aggregates, we stained PfCen1 overexpressing parasites with Proteostat (Fig 5G) [45]. Both structures were negative, suggesting that they are not a mere product of protein aggregation.

Fig 5. PfCen1 displays condensate-like properties in parasites.

Fig 5

(A) Schematic of pFIO plasmids during DiCre-dependent recombination. (B) Immunofluorescence of tubulin and GFP in parasites moderately overexpressing PfCen1-GFP (pFIO). Percentage of early schizonts containing ECCAs (arrows) indicated. (C) as in (B) but for cell strongly overexpressing PfCen1-GFP (pFIO+) (D) Time lapse images of parasites overexpressing PfCen1-GFP from pFIO+ and labeled with microtubule live stain SPY555-Tubulin (E) Normalized mean cytoplasmic PfCen1-GFP fluorescence intensity over time and share of PfCen1-GFP fluorescence signal contained within foci with standard deviation. n > 33. (F) Quantification of timepoint of PfCen1-GFP foci appearance relative to first mitotic spindle formation detected by SPY650-tubulin comparing pFIO/pFIO+; standard error of the mean, two-tailed t-test, n1 = 46, n2 = 45. (G) Proteostat and PfCen1-GFP live cell staining. (H) Schematic of pFIO+ version containing T2A skip peptide and expected translation products. (I) Immunofluorescence of rapamycin-induced and control parasites carrying pFIO+_GFP-T2A-PfCen1 plasmid labelled with anti-PfCen1 and anti-Tubulin antibodies. Arrow heads indicate foci above threshold. All images are MIP. DNA stained with Hoechst. Scale bars; 1 μm. (J) Quantification of cells having non-centrosomal foci (which includes unspecific background dots and ECCAs) in induced (n = 49) and control (n = 53) conditions. Absolute numbers given in columns. (K) Quantification of number of non-centrosomal foci per centriolar plaque.

To exclude that ECCAs only form due to GFP-tagging we designed a version of pFIO+ where GFP and PfCen1 were separated by a T2A skip peptide (Fig 5H). During translation the T2A sequence causes the ribosome to “skip” bond formation between amino acids and produces two separated proteins from the same mRNA [46]. In this parasite line, PfCen1 only contains a single additional N-terminal proline and Western blot analysis of induced parasite lysate confirmed efficient “skipping” (S12 Fig). To visualize the localization of untagged PfCen1 we produced a rat polyclonal anti-PfCen1 antibody, which detected a specific band in parasite protein extract albeit showing some background signal and cross-reactivity with the highly homologous PfCen3 (S13 Fig). Using this antibody, we immunolabeled the rapamycin-induced cells carrying pFIO+_GFP-T2A-PfCen1 and specifically selected GFP-positive ones in the population for imaging (Fig 5I, top panels). Due to unspecific labeling (S13 Fig), the background of the PfCen1 antibody was higher than for the anti-PfCen3 and produced additional unspecific cytoplasmic dots even in non-overexpressing cells (Fig 5I, bottom panels). Therefore, we set an intensity threshold based on centrosome foci intensity to reduce the impact of unspecific signals in the non-induced conditions. We consistently observed more non-centrosomal anti-PfCen1 foci in induced cells and found a higher number of cells carrying non-centrosomal foci in induced parasites, which likely present unspecific dots and ECCAs together (Fig 5J). When looking at the number of non-centrosomal foci detected per centriolar plaque in all cells the effect of PfCen1 overexpression was even more clearly indicating that ECCAs are formed, and their presence does not depend on GFP-tagging (Fig 5K). These data are concordant with a regulated and concentration-dependent condensation mechanism of PfCen1 in vivo.

Hexanediol treatment causes centriolar plaque disassembly

Biomolecular condensates are frequently formed by weak non-polar interactions, that can under some circumstances be dissolved by 1,6-hexanediol. Addition of 5% 1,6-hexanediol to phase-separated PfCen1 in vitro only had a moderate effect on droplet dissolution (Fig 6A). This is compatible with previous observations that centrin assembly also has a strong polar component [26,27]. To probe this in a physiological context we also treated wild type parasites for 5 min with 5% 1,6-hexanediol followed by anti-PfCen1 immunolabeling (Fig 6B). We observed a striking dissolution of centrin foci and more than 74% of spindles lost centrin foci at the centriolar plaque compared to 2% in control cells (Fig 6C), suggesting that non-polar interactions might play a more important role for centrins in vivo or that the centriolar plaque integrity as a whole might be affected. Taken together these observations argue for condensation being part of the mechanism of centrin assembly at the centriolar plaque.

Fig 6. 1,6-hexanediol treatment dissolves centrin foci in vivo.

Fig 6

(A) Turbidity measurements of recombinant PfCen1 solution at 30 μM in 50 mM BisTris (pH 7.1) at 37°C during addition of calcium followed by 5% 1,6-hexanediol and EDTA. (B) Immunofluorescence of non-overexpressing parasites treated with 5% 1,6-hexanediol or untreated control for 5 min stained with anti-PfCen1 and anti-Tubulin antibodies. Images are MIP. DNA stained with Hoechst. Scale bars; 1 μm. (C) Quantification of spindles in treated (n = 110) and control (n = 85) cells (early schizonts) with or without centrin focus at the spindle pole in percentage. Absolute numbers given in columns.

PfCen1 requires its N-terminus and calcium-binding activity for condensation

To obtain insights into the molecular determinants of centrin condensation, we set out to functionally interfere with LLPS in vitro and in vivo. When deleting the IDR-containing N-terminus from recombinant PfCen1 (S2C Fig), we observed strongly reduced LLPS and merely detected aggregation (Fig 7A). LLPS was not rescued by replacement with the IDR-free N-terminus of PfCen4, neither was the N-terminus of PfCen1 sufficient to confer LLPS to a chimeric PfCen4 (S14 Fig). To test the role of EFh domains, we generated a EFh-dead mutant by introducing four critical D to A mutations in the Ca2+-binding pocket, which was shown to strongly inhibit Ca2+-binding (Fig 2C) [47]. Circular dichroism spectroscopy showed that the secondary structure of PfCen1 was not affected by those four point mutations (S15 Fig), yet in this mutant, LLPS was abolished (Fig 7B).To test the significance of the IDR in vivo, we overexpressed the N-terminal deletion mutant, observing ECCAs in only 31% (n = 55) of cells (Fig 7C), as compared to 97% upon pFIO+ overexpression of PfCen1 (Fig 5C). The EFh-dead PfCen1 mutant (Fig 7D), lacked any discernible formation of foci in vivo, suggesting a critical role for Ca2+ responsiveness for targeting and condensation. Together this suggests that active EFh-domains and a disordered N-terminus are essential but not sufficient for calcium-induced phase separation of centrins, with alterations inhibiting LLPS in vitro also affecting foci formation in vivo. However, deletion of the N-terminus retains some targeting activity while EFh-dead PfCen1-GFP stays completely soluble.‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬

Fig 7. PfCen1 phase separation depends on its N-terminus and calcium binding.

Fig 7

(A-B) Turbidity measurements in recombinant protein solutions at 30 μM of PfCen1 mutants lacking the N-terminus or with disabled EFh domains, respectively, during addition of calcium followed by EDTA. Conditions: 50 mM BisTris (pH 7.1) at 37°C. (C-D) Immunofluorescence staining of tubulin and GFP in parasites overexpressing N-terminal deletion and non-Ca2+-binding mutant of PfCen1-GFP from pFIO+. Percentage of cells containing ECCAs (arrows) indicated. All images are MIP. DNA stained with Hoechst. Scale bars; 1 μm. (E) Our findings suggest that centrin accumulation at the centriolar plaque from a pre-mitotic diffuse cytoplasmic pool depends on LLPS, which might be promoted by cellular signaling events like calcium levels and a nucleating factor at the centrosome. Parasite is shown without host red blood cell for clarity.

Discussion

Working model for centrin accumulation

Centrins are conserved throughout eukaryotes and implicated in a wide range of processes, which require their assembly [24]. Our study in an early branching eukaryote reveals calcium-inducible phase separation as a new centrin assembly principle (Fig 7E). Centrins frequently associate with highly structured and polymeric cellular complexes such as the base of flagella and cilia, the inside of centrioles, the basal body and the associated contractile fibers [23,4850]. Yet there is little evidence that centrins themselves form polymers. An early study posited that a centrin of the algae Scherffelia dubia forms a filamentous network visualized by electron microscopy albeit using a protein concentration of 1500 μM [51]. These excessively high concentrations can result in spinodal decomposition, a type of transition into a two-phase regime, where thermodynamic barriers to phase separation disappear and proteins can form network like structures [52]. The diameters of the observed network branches were further too thick to correspond to filamentous arrangement of centrin monomers [51]. An early physicochemical analysis of calcium dependent self-assembly of HsCen2, however, suggested the existence of “more complex energetics of the polymer solution”[26]. The same study showed dependencies of centrin self-assembly on concentration, pH, and temperature all in line with an expected effect on LLPS. While polymerization of centrins cannot be definitively ruled out, our study suggest that LLPS is relevant for their assembly in several cases.

Centrin dynamics and overexpression in human cells

While centrins have been associated with a range of functions including nuclear export, transcription, and DNA excision repair, their association with MTOCs plays a dominant role [24,48,53,54]. We support this notion by confirming that all four centrins are focused at the centriolar plaque in P. falciparum, while other potential localizations are below our detection threshold. MTOCs can be viewed as membrane-less organelles and biomolecular condensation has been ascribed to various centrosomal proteins [39]. Here, the model posits that phase-separating proteins, which can act as scaffold, concentrate so called client proteins [55]. An example is the enrichment of tubulin monomers by SPD-5 to assist and control their polymerization into microtubules [41]. It is, however, important to note that in asexual blood stage parasites the centrin-containing compartment and the spindle microtubule nucleation sites are physically separated by the nuclear membrane [12], while in male gametocytes centriole-like structures that will act as basal body for the growing axonemes are formed in direct proximity to centrin [15]. A study using laser ablation of human centrosomes to study de novo centriole formation showed that it begins with the “coalescence” of small centrin “aggregates” that appear amorphous in EM [56]. In S-phase arrested cells formation of “centrin granules” was observed at the nuclear periphery [57]. HsCen1-GFP overexpression further accentuates formation of nucleus-associated and coalescing centrin granules and causes centrosome overduplication. Another study overexpressing GFP-tagged HsCen2 also found an excess of centrin foci, which caused centriole overproduction, and this effect was reproducible without tag [58]. These structures as well as centriolar satellites in general are reminiscent to the ECCAs we observe in the malaria parasite. The observations that Cdk2 activity was required for centrin foci formation and that the overexpression phenotypes varied between human cell types and stages suggests that foci assembly is regulated [5759].

Role of calcium in centrin assembly

In line with regulated assembly, we observed centrin accumulation, even in overexpressing parasites, only at the entry into the nuclear division stage, while the non-calcium-binding EFh-dead PfCen1 mutant failed to accumulate at all. This calcium dependency of centrin LLPS provides a possible link to calcium signaling, which plays multiple roles [60]. The reported increase in intracellular calcium associated with schizogony could therefore help to promote timely centrin accumulation at the centriolar plaque [61]. Interestingly, human cells display a functional calcium spike at the centrosome during mitosis [62]. Our attempts to reduce intracellular calcium concentrations to impact centrin dynamics in vivo were unfortunately inconclusive. A central caveat is that effective removal of intra-parasitic calcium likely requires lysis of the host red blood cell [61,63,64]. Yet, it is unlikely that centrin accumulation at the centriolar plaque is solely regulated by calcium but rather by various cell cycle regulation pathways, as has been described for human centrins [30,58,59]. Cell cycle regulation could for example influence the phosphorylation status of the N-terminus of PfCen3 (Fig 1B).

Predicting centrin LLPS in vivo

To demonstrate the significance of LLPS in vivo is one of the more challenging aspects of the field, even in model organisms [52,65,66]. As one of the defining features of phase separation the question whether the saturation concentration, csat, for a given protein can be reached in a cell is crucial. In vitro studies can give clues about csat, but solution conditions significantly affect protein behavior [40]. Addition of crowding agents like PEG and decreasing temperature can significantly reduce csat, while addition of salt can increase it. For PfCen1 we found a csat of about 10–15 μM at 37° C while adding neither salt nor PEG. This lies within the range of what has been quantified for other LLPS proteins [42]. In the much more complex environment of a cell the saturation of the dilute phase is determined by a convolution of macromolecular concentrations, and therefore vastly differs from the in vitro conditions, which makes a prediction of csat in vivo challenging [65]. Our observation that PfCen1 and 3 form co-condensates would also require that the joint concentration of both proteins must be known. Measuring intracellular protein concentrations in P. falciparum is challenging, particularly when the endogenous protein, such as is the case with PfCen1-3 cannot be tagged. Here, overexpression offers an opportunity to assess whether phase separation-like behavior of centrins in cells is possible at all and which are the necessary structural features of the protein to form condensate-like structures. Whether centrin overexpression affects parasite fitness remains to be clarified.

Principles affecting saturation concentration

In PfCen1-GFP overexpressing schizonts just before centrin foci appearance (Fig 4D–4F) the cytoplasmic centrin concentration appears to be below the critical threshold. Nevertheless, mechanisms such as surface-assisted condensation and prewetting have been described to promote condensation below the cytoplasmic csat [6771]. Examples ranging from bacteria to human cells have been observed where a polymer enriches a condensing protein [72,73]. In bacteria, e.g., filamentous PomX recruits PomY condensates by surface-assisted condensation, which in turn enrich and bundle bacterial tubulin-like FtsZ polymers. Prewetting can be envisioned as wetting of dewdrops on a spider web and has been described for transcription factors condensing on isolated DNA strands [68]. We previously described a novel Sfi1-like protein (PfSlp) interacting with centrins at the centriolar plaque [43]. It is characterized by a large size, likely taking an elongated shape, and the presence of multiple centrin binding motifs along its sequence, which is itself highly disordered. This offers the potential for multivalent interaction, which can dramatically decrease csat [52]. Whether PfSlp forms antiparallel bundles like yeast Sfi1 along which centrins could form condensates is speculative [74,75], but would be coherent with the dimensions of the stretched PfCen1-Halo signal tangentially to the nucleus (Fig 1E). Deformation of a condensate from a round shape can indeed be achieved through external forces and cytoskeletal elements [70]. The observation that ECCAs are initially formed at the centriolar plaque and therefore the nuclear membrane surface is compatible with a surface-assisted condensation or prewetting transitions. This remains of course highly speculative and it must be investigated further whether non-homotypic interaction, which can either promote or antagonize phase separation, could be the dominant cause of the observations made [66].

Biomolecular condensation manifests on a spectrum

While the ability of individual proteins to phase separate is undisputed by now, the debate whether biomolecular condensation is the dominant principle behind formation of membrane-less organelles, such as the centrosome, is still ongoing [76]. Some of this debate can be attributed to a differential use of nomenclature as biomolecular condensate formation does e.g. not per se imply phase separation [65]. As the field progresses it becomes clear that biomolecular condensation unfolds over a range of interaction types and biophysical properties of proteins and nucleic acids, which has led to proposing the term PS++ for all associated phenomena [65]. Where centrins are positioned within this spectrum and how variable the biophysical properties of centrin condensates are shall be investigated in the future [77].

Potential implications for centriolar plaque biology

What remains is the question whether phase separation is an adequate conceptual framework to understand the functional questions surrounding centriolar plaque biology. What our study shows is that centrins only accumulate in vivo when the parasite is approaching its nuclear division stage and phase separation is not required for all centrins, i.e., PfCen2 and 4, to be recruited to the centriolar plaque. Hence there must be mechanisms that promote timely assembly, but also dissolution, of centrin foci throughout the course of schizogony. As in many cases identifying genuine biologically importance for centrin phase separation remains limited [52]. However, envisioning phase-separating scaffold proteins and recruited clients is useful to conceptualize assembly of the amorphous centriolar plaque [55,78]. Phase separation could help explain how the centriolar plaque remains fluid enough to allow splitting during subsequent nuclear division cycles, while limiting the number of newly forming assemblies [12,15]. Despite the caveats of 1,6-hexanediol treatment [79], the ensuing dissolution of centrin foci are a first indication that biomolecular condensation might play a role in P. falciparum MTOC biology.

Materials and methods

Cloning of plasmids

All plasmids were assembled via Gibson assembly using the HiFi DNA Assembly mix (New England Biolabs), unless stated otherwise. Correct sequences were confirmed via Sanger sequencing (Eurofins Genomics, SupremeRun). PCRs were performed using Phusion polymerase (New England Biolabs). Details on primer sequences, templates, and synthetic oligos or genes are provided in S1 and S2 Tables. Plasmids were amplified in chemically competent 5-alpha F’Iq Escherichia coli cells (New England Biolabs) after 42°C heat shock transformation and extracted using the GenElute HP Plasmid Miniprep Kit (Sigma-Aldrich, Merck). To generate pARL-PfCen1-GFP, -PfCen2-GFP, and PfCen4-GFP from pARL-PfCen3-GFP (kindly provided by Tim Gilberger), the PfCen3 sequence was removed via restriction digest with KpnI-HF and AvrII. It was replaced with PfCen1, PfCen2, or PfCen4 sequences PCR amplified via the primer pairs P1+2, P3+4, or P5+6, respectively. To generate pARL-PfCen1-Halo the GFP sequence was removed from pARL-PfCen1-GFP via restriction digest with AvrII and PstI-HF. It was replaced with the Halo sequence PCR amplified via primer pair P7+P8. To generate the pFIO plasmid pARL-Cen3-GFP was digested with NotI-HF and HindIII-HF, leaving an hrp2 3’UTR. In front of this hrp2 3’UTR a Pfhsp70 5’UTR-LoxP-hDHFR (human dihydrofolate reductase) sequence was inserted from two fragments PCR amplified via primer pairs P9+P10 and P11+12 respectively. This created an intermediate plasmid, which was digested with BamHI-HF (in between the hDHFR and hrp2 3’UTR) to insert an mCherry-LoxP-GFP sequence from two fragments PCR amplified via primer pairs P14+15 and P16+17 respectively. This plasmid was then digested with SalI-HF (in between mCherry and LoxP-GFP) to insert a PbDHFR 3’UTR sequence PCR amplified via primer pair P18+19 to create the basic pFIO_GFP. To generate pFIO+_GFP the promoter was replaced by digestion with NotI-HF and BamHI-HF (which also removed the hDHFR sequence) and integration of Pfhsp86 5’UTR and hDHFR sequences PCR amplified using primer pairs P20+21 and P11+P13 respectively. To generate pFIO/pFIO+_PfCen1-GFP, and pFIO+_ΔN-PfCen1-GFP, previously generated pFIO_GFP and pFIO+_GFP were digested with MluI-HF and XhoI to remove the GFP open reading frame (ORF), which was replaced with a PfCen1-GFP or ΔN-PfCen1-GFP ORF PCR amplified using primer pairs P22+17 or P23+17 respectively. pFIO+_ EFh-dead-PfCen1-GFP, and_HsCen2-GFP were generated by removing the PfCen1 ORF in pFIO+_PfCen1-GFP by digestion with MluI-HF and AvrII, and replacing it with synthesized genestrings (Thermo Fisher) encoding EFh-dead-PfCen1, where aspartate 37, 73, 110, and 146 were mutated to alanine, and HsCen2 codon optimized for P. falciparum (oligo 1 and 2). pFIO+_GFP-T2A-PfCen1, which contained a regular hDHFR gene instead of the hDHFR-mCherry fusion protein, was generated in two steps. First the mCherry sequence was removed from pFIO+_PfCen1-GFP by digestion with BamHI-HF and SalI to insert a ssDNA containing a stop codon (oligo 3) via Gibson assembly. The resulting plasmid was digested with MluI-HF and XhoI removing the PfCen1-GFP ORF and replacing it with a GFP-T2A followed by a PfCen1 sequence PCR amplified using primer pairs P24+P25 and P26+P27 respectively. All plasmodial vectors contained a hDHFR selection cassette conveying resistance to WR99210. pET-28 constructs were generated by digesting pET-28a(+) with NcoI-HF and XhoI and inserting HsCen2 as well as codon optimized PfCen1, ΔN-PfCen1, or PfCen2 sequences PCR amplified using primer pairs P28+29 and P30+31, P32+31, and P34+35 respectively. pET-28_PfCen1-GFP was generated by integrating a PfCen1 and GFP sequence PCR amplified using primer pairs P30+33 and P36+37 respectively. Codon optimized EFh-dead PfCen1, ScCDC31, TbCen2, and CrCen sequences were integrated as synthetic dsDNA oligo 10, oligo 11, oligo 12, and oligo 13 respectively. We generated pZE13d-C, a version of the bacterial expression vector pZE13d with a C-terminal 6His tag. For this purpose, pZE13d was digested with BamHI-HF and PstI-HF. A de novo sequence encoding the 6His tag (followed by BamHI and SalI restriction sites) was formed by annealing oligo 4 and 5 over a 30 min temperature gradient from 95°C to 25°C and integrated via T4 ligase (New England Biolabs). pZE13d-C_PfCen3 and _PfCen4 were generated by digesting pZE13d-C with BamHI-HF and SalI-HF and integrating codon optimized PfCen3 and PfCen4 encoding sequences PCR amplified via primer pairs P38+39 and P40+41. We generated pZE13d-TEV, a version of the bacterial expression vector pZE13d with an N-terminal 6His-Linker-TEV sequence for removal of the 6His-Tag via TEV protease. For this purpose, pZE13d was digested with EcoRV-HF and PstI-HF. The 6His-Linker-TEV encoding sequence (followed by an SfoI restriction site) was integrated as a ssDNA sequence (oligo 14) via Gibson assembly. pZE13d-TEV_PfCen1-4 were generated by digesting pZE13d-TEV via SfoI and integrating PfCen1-4 sequences PCR amplified using primer pair P42+P46, P43+P46, P44+P46, and P45+P46 respectively. All pZE13d derived bacterial vectors contained an ampicillin resistance cassette and all pET-28 derived vectors a kanamycin resistance cassette.

P. falciparum blood culturing

All P. falciparum cell lines were maintained in human O+ erythrocyte cultures with a 2.5% haematocrit in RPMI 1640 medium supplemented with 0.5% AlbuMAX II Lipid Rich bovine serum albumin (Thermo Fisher Scientific), 25 mM Hepes (Sigma-Aldrich), 0.2 mM hypoxanthine (c.c.pro GMbH), and 12.5 μg/ml Gentamycin sulfate (Carl Roth) at pH 7.3 (cRPMI). Cultures were incubated at 37°C in 3% CO2, 5% O2, and 90% humidity at 37°C. Parasitemia was maintained below 5% and determined via Hemacolor staining of blood smears (Sigma-Aldrich, Merck) using a Nikon Eclipse E100 microscope (Nikon Corporation) with 100x oil immersion objective. Depending on the application asexual cycle stages were synchronized to the ring stage by incubation of infected red blood cells (iRBCs) in a 25x volume of prewarmed 5% sorbitol (Sigma-Aldrich) solution at 37°C for 10–15 min, followed by a wash step in cRPMI before return to culture.

P. falciparum transfection

For generation of transgenic parasite lines P. falciparum NF54 served as the acceptor strain for pARL plasmids and 3D7-DiCre (kindly provided by Anthony Holder and Mortiz Treeck) for pFIO plasmids [80,81]. Plasmids were purified from 200 ml transformed E. coli overnight culture (37°C, 130 rpm) via the NucleoBond Xtra Midi Kit (Macherey-Nagel) and precipitated by supplementing 0.1x volume 3 M sodium acetate (Sigma-Aldrich, Merck, pH 5.3) and a 2x volume -20°C ethanol (VWR Chemicals). After overnight incubation at -20°C the DNA was pelleted at 17000g for 30 min at 4°C, washed with 70% ethanol, and air-dried under sterile conditions. For transfection 150 μl of iRBCs with a ≥ 4% ring stage parasitaemia were washed with prewarmed CytoMix [120 mM KCl, 0.15 M CaCl2, 2 mM EGTA, 5 mM MgCl2, 10 mM K2HPO4/KH2PO4, 25 mM Hepes, pH 7.6], then mixed with 100 μg purified plasmids in 30 μl TE buffer [10 mM Tris, 1 mM EDTA, pH 8.0] and 350 μl CytoMix. The mixture was transferred into a pre-cooled (4°C) Gene Pulser Electroporation cuvette (Bio-Rad) and electroporated using the Gene Pulser II system (Bio-Rad) at 310 kV, 950 μF, exponential mode. iRBCs were then transferred to 5 ml pre-warmed cRPMI for 30 min recovery at 37°C before centrifugation at 800g for 2 min and transfer to regular culture. Selection for episomal plasmids began 6 h post transfection and was henceforth maintained with 2.5 nM WR99210 (Jacobus Pharmaceutical Company). Tagging of endogenous PfCen1 and 3 with GFP or HA tag using the selection linked integration system were attempted but unsuccessful and yielded no transfectants despite several attempts [82]. Modification of the endogenous PfCen3 gene via CRISPR/Cas9 failed as well.

pFIO induction

Expression of the second pFIO ORF was induced in synchronous 3D7-DiCre_pFIO/pFIO+ parasite lines approximately 48 h prior to experiments during the schizont stage. 25 μl iRBCs were incubated in 200 μl cRPMI supplemented with 100 nM rapamycin (Sigma-Aldrich, Merck) or 1% DMSO (Sigma-Aldrich, Merck) as a control for 4 h at 37°C. Afterwards cells were pelleted 1 min at 800 g for washing 4 times and cultured in 1 ml cRPMI without selection drug until further processing for imaging or FACS analysis.

GFP quantification via flowcytometry

For flowcytometric quantification of GFP signal in induced 3D7-DiCre pFIO/pFIO+ strains 2.5 μl iRBCs were washed once with RT 0.9% NaCl solution (B. Braun GmbH) and stained with 5 μM SYTO 61 Red Fluorescent Nucleic Acid stain (Thermo Fisher Scientific) for 1 h at 37°C in 0.9% NaCl solution and washed once again afterwards at RT. Cells were analysed at RT using the FACSCanto II (BD Biosciences), first gating erythrocytes in the FSC-A/SSC scatter and then single cells in the FSC-H/FSC-A scatter. SYTO 61 signal was acquired using a 640 nm laser and 660/20 emission filter. Of the positive cells, i.e., iRBCs, multinucleated cells, i.e. schizonts, were selected and the share of GFP positive cells determined via a 488 nm laser and 530/30 nm emission filter, for which the gate cut-off was determined based on the uninduced DMSO control.

P. falciparum protein extraction and Western Blot analysis

For analysis of GFP-T2A-PfCen1 T2A skipping efficiency and rat anti-PfCen1 antibody binding, proteins were first extracted from WT NF54 or 3D7-DiCre_pFIO+ GFP-T2A-PfCen1 parasites treated with rapamycin or DMSO 5 days prior. Parasitemia was assessed via blood smear. iRBCs were washed in prewarmed PBS and parasites isolated from RBCs via 0.15% Saponin/PBS. Cells were pelleted at 3300g for 5 min followed by 3 PBS wash steps. Cells were then boiled in 1x Laemmli/PBS buffer to a final concentration of 107 parasites per 10 μl lysate at 95°C for 10 min. Hemozoin was removed via centrifugation at 21000g for 1 min. 10 μl supernatant parasite lysate or 100 ng recombinant protein were loaded onto 12% Mini-Protean TGX gels (Bio-Rad). For quantification of PfCen1-GFP to endogenous PfCen1 ratio, 125 μl erythrocytes infected with 3D7-DiCre_pFIO+_PfCen1-GFP at 1% parasitemia were treated with rapamycin or DMSO. 48 h later trophozoites and schizonts were purified using a 67.5% Percoll (Cytiva) gradient at 1500 g for 10 min RT. Parasites were briefly washed in PBS. A subset was then seeded to a 35 mm IbidiTreat dish (Ibidi), fixed for 20 min at 37°C in 4% PFA/PBS, stained for 1 h in 1:2000 Hoechst/PBS, before 3x10 min washing steps in PBS. To determine the ratio of GFP expressing cells overview images were acquired in the Hoechst, GFP and Rhodamine channel using the 3x3 Snap functionality of the Axiovert 200 M fluorescence microscope (Zeiss) with a 63x (NA 1.3) oil objective at 103 nm pixel size. Uninduced cells acquired under identical conditions were used to determine the GFP signal threshold for positive cells. The cells that had not been used for imaging were treated in parallel with 0.1% Saponin/PBS. The isolated parasites were pelleted at 3300g for 5 min followed by a wash step and then boiled in 45 μl 1x Laemmli/PBS buffer at 95°C. Hemozoin was removed via centrifugation at 21000g for 1 min. 15 μl of lysate was loaded onto 12% Mini-Protean TGX gels. All SDS-PAGEs were performed at 140 V for 45 min. Protein was then transferred onto a nitrocellulose membrane at 1.3 A, 25 V for 10 min using the Trans-Blot Turbo transfer system (Bio-Rad). The membrane was then blocked with filtered 5% milk/0.5% Tween-20/PBS blocking buffer for 15 min under agitation. Primary antibody staining occurred in the same buffer at 4°C overnight under rotation. In addition to the rat anti-PfCen1 (this study) for staining of PfCen1, mouse anti-GFP (Roche #11814460001) and rabbit anti-PfAldolase (Abcam, #ab207494) were used for GFP and Aldolase staining respectively. Membranes were then washed 3x 10 min with blocking buffer under agitation. Secondary antibody incubation with anti-rabbit-680 (Rockland, #610-744-002), anti-rat-800 (Rockland, #612-145-002), or anti-mouse-800 (Rockland, #610-145-002) was performed in the dark at RT for 1 h under agitation. After 3 final washes with blocking buffer and once with PBS the membrane was analyzed using the LiCor Odyssey CLx system. Signal of bands corresponding to PfCen1-GFP and endogenous PfCen1 were quantified using the Image Studio Lite software v5.2 (LI-COR). The ratio was corrected for the share of the population not expressing PfCen1-GFP,quantified via microscopy as described above.

Immunofluorescence assays

Immunofluorescence assays (IFA) of parasites for confocal and STED microscopy were performed as described previously in detail [83]. In brief, parasites were seeded to concanavalin A (Sigma-Aldrich) coated μSlide 8-Well glass bottom dishes (Ibidi), fixed the next day with 4% PFA (Electron Microscopy Sciences) in PBS (Gibco, Thermo Fisher Scientific) for 20 min at 37°C, treated with 0.1% Triton X-100 (Sigma-Aldrich) and 0.1 mg/ml NaBH4 (Sigma-Aldrich) PBS solutions for permeabilization and quenching of free aldehyde groups. Blocking as well as incubation of primary and secondary antibodies (S3 Table) was performed with 3% w/v Albumin Fraction V (Roth) in PBS. Hoechst 3342 (Thermo Fisher Scientific) was added during secondary antibody incubation at a dilution of 1:1000. Unbound antibodies were washed off with 0.5% Tween-20 (Roth) in PBS.

Centrin foci frequency quantification

To quantify the frequency of ECCAs of PfCen1-GFP for different expression levels or mutants the respective seeded 3D7-DiCre_pFIO/pFIO+ strains were PFA fixed approximately 48 h post induction (or DMSO treatment) and an IFA for staining of DNA and tubulin was performed. In addition, GFP was stained using GFP-booster (ChromoTek gba488) at 1:200 to preserve GFP signal with minimal off-target staining if the sample was analyzed over multiple imaging sessions. In case of quantifying the ECCA frequency of cells overexpressing PfCen1 without tag from pFIO+_GFP-T2A-Cen1 a staining with rat anti-PfCentrin1 was performed. For 3D7-DiCre_pFIO_Cen1-GFP, _pFIO+_Cen1-GFP, and_pFIO+_ΔN-PfCen1-GFP 54, 60, and 51 early schizonts (cells with intranuclear spindle and 1–5 nuclei) positive for GFP-foci were acquired in separate sessions. Foci outside the mitotic spindle poles were considered ECCAs.

For induced and DMSO treated 3D7-DiCre_pFIO+_GFP-T2A-Cen1 53 and 49 early schizonts, in case of the induced population positive for GFP-signal, were acquired. Due to the unspecific signals introduced by the anti-PfCentrin1 antibody an additional cutoff was applied and only foci outside of the mitotic spindle poles with a maximal signal that was at least as high as that of the weakest centrosomal foci were counted.

To determine the effect of 1,6-hexanediole on centrin foci DMSO treated (uninduced) 3D7-DiCre_pFIO+_GFP-T2A-Cen1 the medium of seeded cells was exchanged with pre-warmed cRPMI with 5% (v/v) 1,6-hexanediole for 5 min or left untreated (control), followed by a brief washing step in pre-warmed PBS and PFA fixation. IFA staining against DNA, tubulin, and PfCen1 was performed as described above. 36 1,6-hexanediole treated and 33 untreated early schizonts with at least one mitotic spindle were analyzed.

Individual cells were acquired using the Leica SP8 point laser scanning confocal microscope using an HC PL APO CS2 63x/1.4 N.A. oil immersion objective. 128x128 pixel multichannel images were acquired sequentially using HyD detectors in the standard mode with a pixel size of 72.6 nm and z-interval of 0.3 μm with a pinhole of 1 airy unit.

Analysis was performed using Fiji software [84]. For induced 3D7-DiCre_pFIO-EFh-dead-Cen1-GFP no quantification was performed as no cells with foci were ever found. GFP signal density was quantified using Fiji by applying a threshold (1, 255) to the GFP signal to isolate the cellular signal from the background. Area and raw integrated density of each individual Z-slice was determined via the multimeasure tool. The resulting intensity values were summed up and divided by the total area across all z-slices.

Proteostat staining of ECCA positive cells

To determine if ECCAs are aggregates live seeded 3D7-DiCre_pFIO+_PfCen1-GFP cells were stained with 1:1000 Hoechst 3342 and 1:3000 Proteostat (Enzo Life Sciences) in cRPMI for 30 min at 37°C. Live cells were imaged at 37°C using the Leica SP8 microscope with the Lighting module, enabling automated adaptive deconvolution. 264x264 pixel images were acquired using a 63x/1.4 N.A. oil immersion objective, GaAsP detectors, a pinhole setting of 0.6 airy units, a pixel size of 35.1 nm and z-stack of 7.28 μm with slices at 130 nm intervals. PfCen1-GFP and Proteostat were excited with a 488 nm laser, with GFP emission being measured between 490 to 550 nm and Proteostat emission at 600 to 700 nm. GFP signal bleed-through into the Proteostat range was negligible.

STED microscopy

STED microscopy of NF54-pARL_PfCen1-4 -GFP was performed on an Expert Line STED system (Abberior Instruments GmbH) equipped with SLM based easy 3D module and an Olympus IX83 microscopy body, using an Olympus UPlanSApo 100x oil immersion objective/1.4 NA with a pixel size of 20 nm. STED images on fixed cells were acquired in RescueSTED mode (to avoid structural damage from the STED laser heating up the parasite’s hemozoin crystals) using the 590 and 640 nm excitation laser in line sequential mode with corresponding 615/20 and 685/70 emission filters. A 775 nm STED laser was employed at 10–15% intensity (maximum 3 W) with a pixel dwell time of 10 μs. Regular confocal images were acquired in z-intervals of 300 nm, with 405 nm, 488 nm, 594 nm and 640 nm laser power being adjusted for each cell. Deconvolution of GFP staining signal was performed using Imspector Software (Abberior Instruments GmbH). For live cell STED seeded NF54-pARL_PfCen1-Halo were pre-treated with 1 μM SPY505-DNA (Spirochrome) and 1 μM MaP-SiR-Halo [37] for 3 h in cRPMI, which was replaced with cRPMI made from phenol red-free RPMI 1640 (PAN Biotech) prior to imaging. STED image series were acquired at 37°C in 1–30 second intervals on a single Z-slice using the same laser setup as above. Deconvolution was performed with Huygens professional software using express deconvolution with the standard template.

Quantification of live PfCen1-GFP dynamics during schizogony

For long term live cell imaging of seeded 3D7-DiCre_pFIO/pFIO+-PfCen1-GFP cells induced approximately 48 h prior were pre-incubated for 2 h at 37°C in an airtight 8-well dish with 0.5 μM SPY650-Tubulin in cRPMI made from phenol red-free RPMI 1640 that has been pre-equilibrated in 3% CO2, 5% O2 overnight. Imaging was performed at 37°C at the PerkinElmer UltraVIEW VoX microscope equipped with Yokogawa CSU-X1 spinning disk head and Nikon TiE microscope body with an Apo 60x/1.49 numerical aperture (NA) oil immersion objective and Hamamatsu C9100-23B electron-multiplying charge-coupled device (EM-CCD) camera with a pixel size of 59.8 nm. Images were acquired at multiple position using the automated stage and Perfect Focus System (PFS) in 5 min intervals. Multichannel images were acquired sequentially with 488 nm and 640 nm laser at 3% and 6% laser power as well as DIC. 8 μm stacks were acquired in 500 nm Z-intervals. For determination of the appearance of the first foci relative to the formation the first mitotic spindle the SPY650-tubulin signal was enhanced via deconvolution using the Fiji Deconvolutionlab2 with 10 iterations of the Richardson Lucy algorithm. PSF was generated using the PSF Generator plugin. Cells without visible focus at the start of imaging were visually analysed using Fiji. Mitotic spindle formation was identified by a strong increase in SPY650-tubulin foci signal and reduced mobility during the collapse of the hemispindle at the transition to a mitotic spindle.

For quantification of GFP signal within the cytoplasmic and foci fraction images were processed and analysed in a semi-automated workflow using ImageJ macros in the 64-bit 2.3.0 Fiji distribution of ImageJ. All used macros were deposited on https://github.com/SeverinaKlaus/ImageJ-Macros. Image segmentation was carried out in 3D using version 1.3.2 of the Windows distribution of the image classification software ilastik [85]. 3D timelapse GFP images were cropped to 80x80 pixel images containing individual iRBCs. Only iRBCs containing a single parasite were examined. To facilitate improved segmentation, image size was increased four times to 320x320 pixel using the adjust size function of ImageJ without interpolation. Segmentation of GFP foci was carried out on enlarged images using a pixel classification workflow in ilastik. With ilastik, a Random Forest classifier utilizing all features up to and including a sigma of 3.5 in 3D was trained on two reference GFP timelapses via manual annotation. Subsequently, all 3D GFP timelapse images were batch processed using the same classifier. Segmentation files were exported as multipage tiff and reconstructed into 4D image sets matching the original 80x80 files by reordering stacks and decreasing the image size via the size adjust function of ImageJ without interpolation. Reconstructed segmentation images were then converted into binary masks containing only 0 (background) and 1 (object, here GFP foci) pixel values using the ImageJ math functions. Subsequently, signal intensities for GFP were measured in the following compartments over time: the foci, the whole parasite excluding the foci and the whole parasite including the foci. In parallel, the total area occupied by each compartment at a given time was also quantified. Results were collected as comma separated value (.csv) files and imported into Microsoft excel for analysis using an excel macro. To create masks for the whole parasite, images were segmented on background GFP values. Briefly, a median filter with a radius of 1 and a default threshold of 2200 (2200, 65535) were applied. To create binary parasite masks containing only 0 (background) and 1 (parasite) pixel values the thresholded image was divided by 255 using the ImageJ math functions. To create a mask of the whole parasite excluding the foci, the binary foci mask was inverted using the ImageJ math functions and the inverted foci mask multiplied with the parasite mask using the ImageJ image calculator function. The resulting binary mask contains only 0 (background and foci) and 1 (remaining parasite) pixel values. Areas were measured from binary segmentation masks by applying the multimeasure function on thresholded (1, 255) masks. To measure GFP signal intensities in different compartments, first background subtraction of 2000 was performed on the original 80x80 GFP images. The background subtracted image was then multiplied with one of the binary masks via the ImageJ calculator function, effectively removing any signal outside the compartment of interest. From the 4D image containing only the signal in the areas of interest, a summed z-projection was then created, from which signal intensity was measured as the raw integrated density using the ImageJ multimeasure function. Where indicated data of individual cells was normalized to the average value at the timepoints ranging from 10 min before and after mitotic spindle formation of that cell.

Protein expression and purification

For the expression of PfCen1-6His variants as well as PfCen2-6His, and HsCen2-6His, chemically competent BL21-CodonPlus (De3) cells (Agilent Technologies) were transformed with the respective pET-28 vector via 42°C heat shock and plated overnight. Due to low transformation efficiency a single colony was picked for inoculation of an overnight pre-culture with 50 mg/L kanamycin (Roth), which was diluted 1:50 the next day in pre-warmed LB with kanamycin. For the expression of PfCen3-6His, PfCen4-6His, and pZE13d-TEV-PfCen1-4 chemically competent W3110-Z1 E. coli [86] were transformed with the respective pZE13d vector via 42°C heat shock and plated. The bacteria were scraped off and used to inoculate an expression culture at OD600 of 0.06 in pre-warmed LB with 50 mg/L ampicillin (Roth). These expression cultures were grown at 37°C, shaking at 130 rpm, until induction with 1 mM final IPTG (Thermo Scientific) once an OD600 of 0.5 for W3110-Z1 or 0.7 for BL21 cells was reached, after which incubation continued for 3 and 5 h respectively. All further steps were performed at 4°C. Bacteria were centrifuged and lysed via sonication (Branson Sonifier 250) in lysis buffer [3 mM β-Mercaptoethanol, 20 μg/ml DNaseI, 10 μg/ml Lysozyme, C0mplete protease inhibitor (Sigma-Aldrich), in PBS, pH 7.4]. Lysate was cleared via centrifugation at 17000 g for 20 min, supplemented with imidazole (Roth) to 10 mM, and the soluble fraction transferred to Ni-NTA beads (QIAGEN) in a gravity flow column. Beads were washed with a 10x volume of wash buffer [50 mM NaH2PO4H2O, 300 mM NaCl, pH 8.0] at 20 mM imidazole and protein eluted at 250 mM imidazole. In case of 6His-TEV-PfCen1-4, 6His-TEV protease (EMBL Protein Expression and Purification Core Facility) was added to cleave of the 6His tag (leaving an N-terminal glycine) and buffer exchanged to PBS with 3 mM β-Mercaptoethanol via consecutive 2 h and overnight dialysis in a 300x volume using a 6–8 kDA cut-off tubing (Spectra/Por, 132650) at 4°C. Another round of reverse Ni-NTA purification was then performed to remove the 6His-TEV from the solution, collecting the flowthrough. With these and all other proteins buffer was exchanged to 50 mM BisTris pH 7.1 using the same dialysis protocol. Aliquots were snap-frozen in liquid nitrogen for storage at -80°C and slowly thawed on ice prior to experiments. Purity was determined via Coomassie gel. Concentrations were determined via Pierce 660 nm protein assay (Thermo Fisher) using pure bovine serum albumin (Thermo Fisher) as a standard. Purity was confirmed by loading 1.125 μg of protein on a 12-well 12% Mini-Protean TGX gel (Bio-Rad), performing SDS-PAGE electrophoresis and fixing the protein with 40% methanol, 10% acetic acid solution, and staining with 0.25% Coomassie-blue (Merck) in 50% methanol, 10% acetic acid. Gels were documented with the Li-COR Odyssey CLx (Li-COR Biosciences) at 700 nm. Correct protein sizes were confirmed via LC-MS by the CFMP at the ZMBH Heidelberg, using a maXis UHR-TOF (Bruker Daltonics) coupled with nanoUPLC Acquity (Waters) tandem mass spectrometer for intact protein detection.

Antibody generation

For generation of polyclonal rat anti-PfCentrin1, PfCentrin1-6His was additionally purified via size exclusion chromatography as described previously [12]. Immunization was performed by Davids-Biotechnology using a 250 μg, 63 day, 5 injection immunization regimen. Anti-PfCen1 rat serum was used for all assays, without further affinity purification.

LLPS quantification and imaging

To quantify LLPS over time 350 μl of protein sample solutions in 50 mM BisTris buffer at pH 7.1 were prepared in a 1.5 ml polystyrene cuvette (Sarstedt) on ice and transferred into a NP80 nanophotometer (Implen), which was blanked with buffer and preheated to 37°C. In case of PfCen1-GFP-6His the protein solution itself was used for blanking due to absorption of GFP. The OD200-900 10 mm pathlength was then measured in 10 s intervals for 25 min, or 1 min intervals for up to 3 h in case of long-term measurements. At 450 s 3.5 μl 200 mM CaCl2 or MgCl2 solution was added to 2 mM (first 330 s not shown), and at 1170 s 7 μl 500 mM EDTA solution to 10 mM. To ensure even distribution of the solutions during addition into the cuvette they were pre-loaded into a 200 μl pipette tip, which was used to pipette sample solution up and down three times in between two measurements. To measure the effect of 1,6-hexanediole 39 μl of a 50% (v/v) solution in ddH2O was added at 1170 s in the same manner. To easily detect droplet fusion events, we used increased centrin concentrations for the movies (PfCen1-6His, 200 μM. PfCen2-6His, 120 μM. PfCen3-6His, 193 μM. PfCen4-6His, 120 μM. HsCen2-6His, 200 μM). Otherwise, 30 μM was used or as indicated. 20 μl protein sample were imaged in non-binding PS μCLEAR 384 well plates (Greiner). For fluorescent imaging the 30 μM protein solutions were supplemented with 300 nM (100:1 molar ratio) NTA-Atto 550 (Sigma Aldrich, Merck). Movies were acquired at 37°C with a PerkinElmer UltraVIEW VoX microscope equipped with Yokogawa CSU-X1 spinning disk head and Nikon TiE microscope body with an Apo 60x/1.49 NA oil immersion objective and Hamamatsu sCMOS OrCA Flash 4.0 camera with a pixel size of 89.7 nm. Image series were taken in 1 s intervals using differential interference contrast (DIC) and 561 nm laser. For addition of 0.2 μl 200 mM CaCl2 solution or 0.4 μl 500 mM EDTA solution to the well the plate was briefly removed from the microscope for access. To assess co-condensation 150 μl of a 30 μM PfCen3-6His was imaged inside an untreated μSlide 8-Well glass bottom dishes (Ibidi), induced with 1.5 μl 200 mM CaCl2 solution, and supplemented during imaging with 20 μl PfCen1-GFP-6His directly into the well to a final concentration of 30 μM. GFP was excited using a 488 nm laser.

Analysis of N-terminal IDRs in centrins

Likelihood of IDRs was estimated using the IUPred3 tool (www.iupred3.elte.hu) [87]. Centrins with a ≥50% likelihood for N-terminal IDRs were considered positive. The phylogenetic tree was generated using ClustalOmega (www.ebi.ac.uk/Tools/msa/clustalo/), using default settings.

Circular dichroism spectroscopy of recombinant centrins

Recombinant wild type Cen1-6His or mutant EFh-dead PfCen1-6His was diluted with size exclusion chromatography (SEC) buffer, 50 mM Tris-HCl pH 7.1 at 4°C, to 0.4 ml. The samples were injected onto a Superdex S200 10/300 column (equilibrated in SEC buffer) running at a flow rate of 0.75 ml/min in the SEC buffer. Samples from the different fractions were loaded on 4–20% Mini-PROTEAN TGX Precast Gels (Bio-Rad, 4561095) and run under denatured and reduced conditions using Tris/glycine/SDS running buffer (Bio-Rad, 1610772). The gel was run for 15–17 min at 300 V and stained with Coomassie Blue. Fractions with highly purified protein were diluted into the SEC buffer to a final concentration of 0.5 mg/ml and centrifuged for 10 min at maximal speed prior to the circular dichroism (CD) measurements. CD spectra were recorded using a Jasco J-815 CD spectrophotometer using a 0.2 mm pathlength CD Quartz cuvette, at 20°C, between 260 nm to 190 nm, with 50 nm/min scan speed, digital integration time of 1 sec, a bandwidth of 1 nm, a data-pitch of 0.1 nm and 10 accumulations were averaged. A buffer spectrum was first recorded as baseline and subtracted from the sample spectrum. The spectra were analysed with the Contin-LL [88] method with the protein reference data 7 [89] using the Dichroweb server [90].

Statistics

Statistical significance of the difference in the timepoint of PfCen1-GFP foci appearance between pFIO and pFIO+ (Fig 4F) was assessed via a two-tailed t-test with n = 46 and n = 45 respectively. Significance of difference in centrosomal PfCen1 foci size in induced and control cells (S9 Fig) was assessed using a t-test with Welch’s correction with n = 31 and 23 respectively.

Supporting information

S1 Fig. Schematic map of pARL vector used for ectopic expression of tagged centrins.

The pARL vector contains a hDHFR cassette, conferring resistance to antifolates, and drives expression of a gene or fusion gene of choice from a weakened promoter of the P. falciparum chloroquine resistance transporter (Pfcrt).

(TIF)

S2 Fig. Recombinantly produced centrins have full length size.

(A) Coomassie gels of wild type centrins recombinantly produced in bacteria and purified via their C-terminal 6His tag show slightly lower migration than expected for PfCen2-6His and PfCen-4-6His (B) Mass spectrometry analysis of native proteins, however, confirms full length expression for all wild type centrins except for cleavage of methionine 1 and occasional detection of degradation bands. (C) Coomassie gels of mutant, tagged and tag-free centrin versions confirms proper expression and show expected migration. Non-plasmodium centrins are T. brucei centrin A (Accession number: XP_846945) 22 kDa, C. reinhardtii centrin (Accession number: P05434) 20 kDa, and S. cerevisiae centrin (Cdc31) 19 kDa.

(TIF)

S3 Fig. Centrin phase-separation also occurs at lower concentrations and is calcium specific.

(A) Transmission light images of recombinant PfCen1-6His, PfCen3-6His, and HsCen2-6His centrin protein solutions at 30 μM concentration before, after calcium, and EDTA addition. Proteins were fluorescently labeled via their 6His tag using 300 nM NTA-Atto 550. Time stamps indicate time elapsed between calcium or EDTA addition and image acquisition. Observed droplets are more sparse than in highly concentrated solution but are still dynamic. (B) Turbidity assay using addition of magnesium followed by calcium addition at the same concentration indicates Ca2+ specifically. and not bivalent cations per se, induces centrin LLPS. (C) Testing different PfCen1-6His concentrations reveals saturation concentration to be below 15 μM. (D) Turbidity assay with recombinant PfCen1-GFP at 20 μM. (E) Turbidity assay with recombinant PfCen1-4 after proteolytic cleavage of any protein tag using various concentrations as indicated. Scale bar: 10 μm. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 or MgCl2 to 2 mM and EDTA to 10 mM, 37°C.

(TIF)

S4 Fig. Non-reversible condensate fraction of PfCen3 increases over time.

(A) Turbidity of PfCen3-6His solution with varying time points of EDTA addition after Calcium addition. (B) Turbidity of PfCen1-6His protein solution with highly delayed EDTA addition shows no irreversible fraction. Overall reduction of turbidity could be explained by protein droplets settling down. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C.

(TIF)

S5 Fig. Phase-separating centrins contain intrinsic disordered regions in their N-terminus.

(A) Using the IUpred 3.0 prediction software we identified a higher intrinsic disorder region probability (red line) in centrins undergoing LLPS in vitro. The highest probabilities are found in the N-terminus before the EFh domains. (B) Using Clustal Omega provided by the EMBL European Bioinformatics Institute we created a phylogenetic tree of centrins from multiple highly divergent eukaryotes, for several of which centrin self-assembly has been shown in vitro in this and previous studies (*). Using IUpred 3.0 we determined centrins with an IDR probability above the 0.5 threshold (red) or without increased IDR probability (blue). Centrins analyzed in this study are in bold.

(TIF)

S6 Fig. PfCen1 and 3, but not PfCen2 and 4 contribute to co-condensation.

Turbidity measurements of recombinant centrins at individually subcritical concentrations either independently or as a mixture during addition of calcium followed by EDTA as indicated. All conditions: 50 mM BisTris (pH 7.1) at 37°C.

(TIF)

S7 Fig. pFIO constructs enable robust inducible overexpression of PfCen1-GFP in malaria parasites.

(A) Flow cytometry analysis of multinucleated malaria parasites (stained with SYTO 61 as a DNA marker) expressing PfCen1-GFP using the classical pARL construct only detects a small fraction of GFP-positive cells with a low median fluorescence intensity. (B) Fraction of GFP-positive parasites strongly increases upon induction of pFIO-PfCen1-GFP transfected cells by rapamycin addition. Median GFP fluorescence intensity is much higher than in pARL whereas the hsp86 promoter generates even higher values than the hsp70 promoter fragment.

(TIF)

S8 Fig. Overexpression levels of pFIO+_PfCen1-GFP.

Western blot analysis of purified 3D7-DiCre_pFIO+_PfCen1-GFP late-stage parasites treated with rapamycin or DMSO (control) in the previous cycle. The signal of endogenous centrin (19.6 kDa, 93 AU) and PfCen1-GFP (46.5 kDa, 717 AU) stained with rat anti-PfCen1 was quantified. Corrected for PfCen1-GFP being only present in a subset of the population (43%, n = 662), as quantified via microscopy, an average (induced) cell has an approximate PfCen1:PfCen1-GFP ratio of 1:18. Staining with anti-PfAldolase was employed as a loading control. Anti-GFP staining indicated no cleavage of PfCen1-GFP, with no expression being detected in the DMSO treated populations with either staining. An additional band at ~21 kDa in the anti-PfCen1 staining is likely the result of cross-reactivity with PfCen3 (20.9 kDa).

(TIF)

S9 Fig. ECCA appearance correlates with Cen1-GFP expression levels.

(A) Graph shows total arbitrary GFP fluorescence intensity of cells transfected with pFIO/pFIO+_PfCen1-GFP one asexual cycle after induction, plotted against the fraction of centrin foci, which are ECCAs per centriolar plaque associated centrin foci. Despite the low r-squared value statistical analysis indicate that the slope is significantly not zero (p<0.0001) and therefore positively correlated. (B) as in A but measured for pFIO+_PfCen1-GFP expressing cells. Slope of linear regression is also significantly not zero (p<0.033) as determined by an F-test. Due to the different expression levels different excitation laser settings had to be used for both parasite lines.

(TIF)

S10 Fig. Dimensions of the anti-PfCen1 signal at the centriolar plaque in overexpressing parasites.

Quantification of immunofluorescence signal at the centriolar plaque measured as in Fig 1D–1E using anti-PfCen1 labeling in rapamycin-induced parasites overexpressing PfCen1-GFP vs control. Using t-test with Welch’s correction width (321 vs 324 nm) shows no difference between the conditions while the height of the signal (247 vs 219 nm) was statistically higher in the induced parasites (p = 0.0081).

(TIF)

S11 Fig. Centrin signal concentration in foci is constant prior to spindle formation.

Mean PfCen1-GFP fluorescence intensity by segmented cellular region in induced parasites carrying pFIO+_PfCen1-GFP relative to mitotic spindle formation in time lapse movies. N > 32.

(TIF)

S12 Fig. T2A skipping is very efficient in pFIO+_GFP-T2A-PfCen1.

Western blot analysis of protein extract from rapamycin-induced and control late-stage parasites carrying pFIO+_GFP-T2A-PfCen1 plasmid. Anti-GFP antibody was used for detection and anti-PfAldolase as a loading control. Rapamycin-induced parasite extract shows a clear band at the expected size (arrow) for “skipped” GFP while the band for the “unskipped” product is barely detectable.

(TIF)

S13 Fig. Crossreactivity of rat anti-PfCen1 antibody.

Western blot analysis using newly generated rat anti-PfCen1 antibody. Antibody was tested against total parasite protein extract of late stage wild type NF54 (left lane) and recombinant PfCen1-4-6His proteins (right lanes). Aside some unspecific background the antibody detects a band of the expected size (20 kDa) in parasite extract. Anti-PfCen1 strongly crossreacts with recombinant PfCen3-6His. Two different contrast adjustments of the same blot are shown.

(TIF)

S14 Fig. PfCen1 N-terminus is essential but not sufficient for centrin phase separation.

(A) Turbidity of chimeric centrin fused from disordered N-terminus of PfCen1 and EFh domain containing part of PfCen4 during calcium and EDTA addition to protein solution. (B) Turbidity of chimeric centrin fused from N-terminus of PfCen4 and EFh domain containing part of PfCen1 during calcium and EDTA addition to protein solution. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C.

(TIF)

S15 Fig. EFh-dead point mutations have no substantial effect on the secondary structures of PfCentrin1 protein.

CD spectra of recombinant PfCen1-6His (black) and EFh-dead PfCen1-6His mutant (magenta) protein show no difference. Calculated secondary structure fractions from the CONTIN-LL analysis method of wild type PfCen1 vs mutant PfCen1 yielded 24.7% vs 24.6% helices, 23.0% vs 22.9% strands, 15.8% vs 15.9% turns, and 36.5% vs 36.6% unordered regions, respectively.

(TIF)

S1 Table. Primers used in this study.

All primers used for amplification of the various construct fragments used for molecular cloning as described above are listed here. Homology regions for Gibson Assembly are in lowercase, PCR binding sequences are capitalized. * Kindly provided by Dr. Friedrich Frischknecht.

(PDF)

S2 Table. Oligos used in this study.

Lowercase letters indicate Gibson assembly or ligation overhangs. All listed ds DNA oligos used for molecular cloning were ordered as GeneArt Strings (ThermoFisher).

(PDF)

S3 Table. Antibodies used in this study.

List of antibodies with information of species, final dilution and source with order number. Starred (*) are dilutions for confocal IFAs. For STED microscopy concentration was increased to 1:200.

(PDF)

S1 Movie. Some PfCen1-Halo foci display round fluid-like dynamics.

STED time lapse movie at 1 s time interval of centriolar plaque region of parasites expressing PfCen1-Halo labeled with MaP-SiR-Halo dye (green). DNA stained with SPY505-DNA (blue). Scale bar, 100 nm. Linear bleaching correction was applied using Fiji.

(AVI)

S2 Movie. Some PfCen1-Halo foci display stretched fluid-like dynamics.

STED time lapse movie at 1 s time interval of centriolar plaque region of parasites expressing PfCen1-Halo labeled with MaP-SiR-Halo dye (green). DNA stained with SPY505-DNA (blue). Scale bar, 100 nm. Linear bleaching correction was applied using Fiji.

(AVI)

S3 Movie. PfCen1 displays LLPS upon calcium addition in vitro.

Transmission time lapse imaging of recombinant PfCen1-6His protein solution at 200 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

(AVI)

S4 Movie. PfCen3 displays LLPS upon calcium addition in vitro.

Transmission time lapse imaging of recombinant PfCen3-6His protein solution at 193 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

(AVI)

S5 Movie. HsCen2 displays LLPS upon calcium addition in vitro.

Transmission time lapse imaging of recombinant HsCen2-6His protein solution at 200 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

(AVI)

S6 Movie. PfCen3 droplets are not fully resolved by EDTA and display more solid-like properties.

Transmission time lapse imaging of recombinant PfCen3 protein solution at 193 μM concentration after calcium and EDTA addition does not dissolve droplets. Remaining spheres don’t display fusion or wetting anymore. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

(AVI)

S7 Movie. PfCen3 displays LLPS upon calcium addition in vitro at temperatures below 37°C.

Transmission time lapse imaging of recombinant PfCen3-6His protein solution at 193 μM concentration displays wetting and fusion events rapidly after calcium addition for longer at lower temperatures. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 32.5°C. Image dimensions are 50 x 50 μm.

(AVI)

S8 Movie. Calcium-induced TbCenA droplets are fusogenic.

Transmission time lapse imaging of recombinant TbCenA-6His protein droplets in solution at 100 μM concentration displays fusion events after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

(AVI)

S9 Movie. Calcium-induced ScCdc31 droplets display surface wetting.

Transmission time lapse imaging of recombinant ScCdc31-6His protein droplets in solution at 200 μM concentration displays surface after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

(AVI)

S10 Movie. Calcium-induced CrCen droplets display surface wetting.

Transmission time lapse imaging of recombinant CrCen-6His protein droplets in solution at 100 μM concentration displays surface after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

(AVI)

S11 Movie. PfCen1-GFP overexpression causes ECCA formation.

Live cell spinning disk time lapse movie at 5 min time intervals of parasite overexpressing PfCen1-GFP (green) from pFIO+ labeled with SPY650-Tubulin (magenta) during entry into schizogony at 37°C. Image dimensions are 15 x 15 μm. Left frame only shows PfCen1-GFP signal. Maximum intensity projection.

(AVI)

S12 Movie. ECCAs frequently form at centriolar plaques before detaching.

Short live cell spinning disk time lapse movie at 5 min time interval of schizont parasite overexpressing PfCen1-GFP (green) from pFIO+ labeled with SPY650-Tubulin (magenta) showing detachment of the brightest foci from the spindle. Image dimensions are 15 x 15 μm. Left frame only shows microtubule signal. Maximum intensity projection.

(AVI)

Acknowledgments

We thank: The Infectious Diseases Imaging Platform for imaging support and use of their microscopes (idip-heidelberg.org). PlasmoDB.org for their Plasmodium Informatics Resources. Core Facility for Mass Spectrometry & Proteomics (ZMBH). Nicolas Lardon and Kai Johnsson (Max Planck Institute for Medical Research) for providing the MaP-SiR-Halo dye. Anthony Holder and Moritz Treeck for the 3D7 DiCre strain. Marina Iocca for help with molecular cloning and protein expression. Arne Börgel and Karine Lapouge from the EMBL-Heidelberg Protein Expression and Purification Core Facility for carrying out size exclusion chromatography and CD spectroscopy analysis. Friedrich Frischknecht, Sebastian Baumgarten, and Daniel Gerlich for critical discussion of the manuscript.

Data Availability

All data is provided in the manuscript or supplemental information. Image analysis macros are deposited on https://github.com/SeverinaKlaus/ImageJ-Macros.

Funding Statement

This work was supported by the German Research Foundation (DFG) 349355339 to J.G, the Human Frontiers Science Program (HFSP) CDA00013/2018-C to J.G, the Chica and Heinz Schaller Foundation to J.G, the Studienstiftung des Deutschen Volkes to Y.V, The German Research Foundation (DFG) 240245660 - SFB 1129 to M.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.WHO. WHO Global, World Malaria Report 2021. Word Malaria report Geneva: World Health Organization. (2021). Licence: CC. 2021. [Google Scholar]
  • 2.Francia ME, Striepen B. Cell division in apicomplexan parasites. Nat Rev Microbiol. 2014;12: 125–136. doi: 10.1038/nrmicro3184 [DOI] [PubMed] [Google Scholar]
  • 3.White MW, Suvorova ES. Apicomplexa Cell Cycles: Something Old, Borrowed, Lost, and New. Trends in Parasitology. 2018;34: 759–71. doi: 10.1016/j.pt.2018.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Matthews H, Duffy CW, Merrick CJ. Checks and balances? DNA replication and the cell cycle in Plasmodium. Parasites and Vectors. 2018;11: 216. doi: 10.1186/s13071-018-2800-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gubbels MJ, Coppens I, Zarringhalam K, Duraisingh MT, Engelberg K. The Modular Circuitry of Apicomplexan Cell Division Plasticity. Frontiers in Cellular and Infection Microbiology. 2021;11: 670049. doi: 10.3389/fcimb.2021.670049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Voß Y, Klaus S, Guizetti J, Ganter M. Plasmodium schizogony, a chronology of the parasite’s cell cycle in the blood stage. PLOS Pathogens. 2023;19: e1011157–e1011157. doi: 10.1371/journal.ppat.1011157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Simon CS, Stürmer VS, Guizetti J. How Many Is Enough?—Challenges of Multinucleated Cell Division in Malaria Parasites. Frontiers in Cellular and Infection Microbiology. 2021;11: 658616. doi: 10.3389/fcimb.2021.658616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schofield L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunology and Cell Biology. 2007;85: 130–137. doi: 10.1038/sj.icb.7100040 [DOI] [PubMed] [Google Scholar]
  • 9.Ito D, Bettencourt-Dias M. Centrosome remodelling in evolution. Cells. 2018;7: 71. doi: 10.3390/cells7070071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tomasina R, González FC, Francia ME. Structural and Functional Insights into the Microtubule Organizing Centers of Toxoplasma gondii and Plasmodium spp. Microorganisms. 2021;9: 2503. doi: 10.3390/microorganisms9122503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gerald N, Mahajan B, Kumar S. Mitosis in the human malaria parasite plasmodium falciparum. Eukaryotic Cell. 2011;10: 474–482. doi: 10.1128/EC.00314-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Simon CS, Funaya C, Bauer J, Voβ Y, Machado M, Penning A, et al. An extended DNA-free intranuclear compartment organizes centrosome microtubules in malaria parasites. Life Science Alliance. 2021;4: e202101199. doi: 10.26508/lsa.202101199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Roques M, Stanway RR, Rea EI, Markus R, Brady D, Holder AA, et al. Plasmodium centrin Pb CEN-4 localizes to the putative MTOC and is dispensable for malaria parasite proliferation. Biology Open. 2019;8: bio036822. doi: 10.1242/bio.036822 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mahajan B, Selvapandiyan A, Gerald NJ, Majam V, Zheng H, Wickramarachchi T, et al. Centrins, cell cycle regulation proteins in human malaria parasite Plasmodium falciparum. The Journal of biological chemistry. 2008;283: 31871–31883. doi: 10.1074/jbc.M800028200 [DOI] [PubMed] [Google Scholar]
  • 15.Rashpa R, Brochet M. Expansion microscopy of Plasmodium gametocytes reveals the molecular architecture of a bipartite microtubule organisation centre coordinating mitosis with axoneme assembly. PLOS Pathogens. 2022;18: e1010223. doi: 10.1371/journal.ppat.1010223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carvalho-Santos Z, Machado P, Branco P, Tavares-Cadete F, Rodrigues-Martins A, Pereira-Leal JB, et al. Stepwise evolution of the centriole-assembly pathway. Journal of Cell Science. 2010;123: 1414–1426. doi: 10.1242/jcs.064931 [DOI] [PubMed] [Google Scholar]
  • 17.Dantas TJ, Daly OM, Morrison CG. Such small hands: The roles of centrins/caltractins in the centriole and in genome maintenance. Cellular and Molecular Life Sciences. 2012;69: 2979–2997. doi: 10.1007/s00018-012-0961-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Salisbury JL. A mechanistic view on the evolutionary origin for centrin-based control of centriole duplication. Journal of Cellular Physiology. 2007;213: 420–428. doi: 10.1002/jcp.21226 [DOI] [PubMed] [Google Scholar]
  • 19.Rüthnick D, Schiebel E. Duplication and Nuclear Envelope Insertion of the Yeast Microtubule Organizing Centre, the Spindle Pole Body. Cells. 2018;7: 42. doi: 10.3390/cells7050042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rüthnick D, Schiebel E. Duplication of the Yeast Spindle Pole Body Once per Cell Cycle. Molecular and Cellular Biology. 2016;36: 1324–1331. doi: 10.1128/MCB.00048-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Salisbury JL, Suino KM, Busby R, Springett M. Centrin-2 is required for centriole duplication in mammalian cells. Current Biology. 2002;12: 1287–1292. doi: 10.1016/s0960-9822(02)01019-9 [DOI] [PubMed] [Google Scholar]
  • 22.Laporte MH, Bouhlel IB, Bertiaux E, Morrison CG, Giroud A, Borgers S, et al. Human SFI1 and Centrin form a complex critical for centriole architecture and ciliogenesis. The EMBO Journal. 2022;n/a: e112107. doi: 10.15252/embj.2022112107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Le Guennec M, Klena N, Gambarotto D, Laporte MH, Tassin AM, van den Hoek H, et al. A helical inner scaffold provides a structural basis for centriole cohesion. Science Advances. 2020;6: eaaz4137–eaaz4137. doi: 10.1126/sciadv.aaz4137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pedretti M, Bombardi L, Conter C, Favretto F, Dominici P, Astegno A. Structural basis for the functional diversity of centrins: A focus on calcium sensing properties and target recognition. International Journal of Molecular Sciences MDPI; Nov, 2021. p. 12173. doi: 10.3390/ijms222212173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cox JA, Tirone F, Durussel I, Firanescu C, Blouquit Y, Duchambon P, et al. Calcium and magnesium binding to human centrin 3 and interaction with target peptides. Biochemistry. 2005;44: 840–850. doi: 10.1021/bi048294e [DOI] [PubMed] [Google Scholar]
  • 26.Tourbez M, Firanescu C, Yang A, Unipan L, Duchambon P, Blouquit Y, et al. Calcium-dependent self-assembly of human centrin 2. Journal of Biological Chemistry. 2004. doi: 10.1074/jbc.M404996200 [DOI] [PubMed] [Google Scholar]
  • 27.Conter C, Bombardi L, Pedretti M, Favretto F, Di Matteo A, Dominici P, et al. The interplay of self-assembly and target binding in centrin 1 from Toxoplasma gondii. Biochemical Journal. 2021;478: 2571–2587. doi: 10.1042/BCJ20210295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhao Y, Song L, Liang A, Yang B. Characterization of self-assembly of Euplotes octocarinatus centrin. Journal of Photochemistry and Photobiology B: Biology. 2009;95: 26–32. doi: 10.1016/j.jphotobiol.2008.12.006 [DOI] [PubMed] [Google Scholar]
  • 29.Zhao Y, Guo X, Yang B. Calcium-induced human centrin 1 self-assembly and double-regulating the binding with peptide R18-Sfi1p. International Journal of Biological Macromolecules. 2019;128: 314–323. doi: 10.1016/j.ijbiomac.2019.01.096 [DOI] [PubMed] [Google Scholar]
  • 30.Sawant DB, Majumder S, Perkins JL, Yang CH, Eyers PA, Fisk HA. Centrin 3 is an inhibitor of centrosomal Mps1 and antagonizes centrin 2 function. Molecular Biology of the Cell. 2015;26: 3741–3753. doi: 10.1091/mbc.E14-07-1248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bushell E, Gomes AR, Sanderson T, Anar B, Girling G, Herd C, et al. Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Cell. 2017;170: 260–272.e8. doi: 10.1016/j.cell.2017.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang M, Wang C, Otto TD, Oberstaller J, Liao X, Adapa SR, et al. Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Science. 2018;360: eaap7847. doi: 10.1126/science.aap7847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lasonder E, Treeck M, Alam M, Tobin AB. Insights into the Plasmodium falciparum schizont phospho-proteome. Microbes and Infection. 2012. doi: 10.1016/j.micinf.2012.04.008 [DOI] [PubMed] [Google Scholar]
  • 34.Ganter M, Goldberg JM, Dvorin JD, Paulo JA, King JG, Tripathi AK, et al. Plasmodium falciparum CRK4 directs continuous rounds of DNA replication during schizogony. Nature Microbiology. 2017;2: 17017–. doi: 10.1038/nmicrobiol.2017.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pease BN, Huttlin EL, Jedrychowski MP, Talevich E, Harmon J, Dillman T, et al. Global analysis of protein expression and phosphorylation of three stages of plasmodium falciparum intraerythrocytic development. Journal of Proteome Research. 2013;12: 4028–4045. doi: 10.1021/pr400394g [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Treeck M, Sanders JL, Elias JE, Boothroyd JC. The phosphoproteomes of plasmodium falciparum and toxoplasma gondii reveal unusual adaptations within and beyond the parasites’ boundaries. Cell Host and Microbe. 2011. doi: 10.1016/j.chom.2011.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lardon N, Wang L, Tschanz A, Hoess P, Tran M, D’Este E, et al. Systematic Tuning of Rhodamine Spirocyclization for Super-resolution Microscopy. Journal of the American Chemical Society. 2021;143: 14592–14600. doi: 10.1021/jacs.1c05004 [DOI] [PubMed] [Google Scholar]
  • 38.Shin Y, Brangwynne CP. Liquid phase condensation in cell physiology and disease. Science. 2017;357: eaaf4382. doi: 10.1126/science.aaf4382 [DOI] [PubMed] [Google Scholar]
  • 39.Woodruff JB, Hyman AA, Boke E. Organization and Function of Non-dynamic Biomolecular Condensates. Trends in Biochemical Sciences. 2018;43: 81–94. doi: 10.1016/j.tibs.2017.11.005 [DOI] [PubMed] [Google Scholar]
  • 40.Alberti S, Saha S, Woodruff JB, Franzmann TM, Wang J, Hyman AA. A User’s Guide for Phase Separation Assays with Purified Proteins. Journal of Molecular Biology. 2018;430: 4806–4820. doi: 10.1016/j.jmb.2018.06.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Woodruff JB, Ferreira Gomes B, Widlund PO, Mahamid J, Honigmann A, Hyman AA. The Centrosome Is a Selective Condensate that Nucleates Microtubules by Concentrating Tubulin. Cell. 2017;169: 1066–1077.e10. doi: 10.1016/j.cell.2017.05.028 [DOI] [PubMed] [Google Scholar]
  • 42.Li Q, Peng X, Li Y, Tang W, Zhu J, Huang J, et al. LLPSDB: a database of proteins undergoing liquid–liquid phase separation in vitro. Nucleic Acids Research. 2020;48: D320–D327. doi: 10.1093/nar/gkz778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wenz C, Simon CS, Romão TP, Stürmer VS, Machado M, Klages N, et al. An Sfi1-like centrin-interacting centriolar plaque protein affects nuclear microtubule homeostasis. PLOS Pathogens. 2023;19: e1011325. doi: 10.1371/journal.ppat.1011325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bertiaux E, Balestra A, Bournonville L, Brochet M, Guichard P, Hamel V. Expansion Microscopy provides new insights into the cytoskeleton of malaria parasites including the conservation of a conoid. PLoS Biol. 2021;19: e3001020–e3001020. doi: 10.1371/journal.pbio.3001020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Biosca A, Bouzón-Arnáiz I, Spanos L, Siden-Kiamos I, Iglesias V, Ventura S, et al. Detection of protein aggregation in live Plasmodium parasites. Antimicrobial Agents and Chemotherapy. 2020;64: e02135–19. doi: 10.1128/AAC.02135-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wagner JC, Goldfless SJ, Ganesan SM, Lee MC, Fidock DA, Niles JC. An integrated strategy for efficient vector construction and multi-gene expression in Plasmodium falciparum. Malar J. 2013;12: 373. doi: 10.1186/1475-2875-12-373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Geiser JR, van Tuinen D, Brockerhoff SE, Neff MM, Davis TN. Can calmodulin function without binding calcium? Cell. 1991;65. doi: 10.1016/0092-8674(91)90547-c [DOI] [PubMed] [Google Scholar]
  • 48.Zhang Y, He CY. Centrins in unicellular organisms: Functional diversity and specialization. Protoplasma. 2012. doi: 10.1007/s00709-011-0305-2 [DOI] [PubMed] [Google Scholar]
  • 49.Salisbury JL, Baron A, Surek B, Melkonian M. Striated flagellar roots: isolation and partial characterization of a calcium-modulated contractile organelle. Journal of Cell Biology. 1984;99: 962–970. doi: 10.1083/jcb.99.3.962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Geimer S, Melkonian M. Centrin scaffold in Chlamydomonas reinhardtii revealed by immunoelectron microscopy. Eukaryot Cell. 2005;4: 1253–1263. doi: 10.1128/EC.4.7.1253-1263.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wiech H, Geier BM, Paschke T, Spang A, Grein K, Steinkötter J, et al. Characterization of green alga, yeast, and human centrins. Specific subdomain features determine functional diversity. J Biol Chem. 1996;271: 22453–22461. doi: 10.1074/jbc.271.37.22453 [DOI] [PubMed] [Google Scholar]
  • 52.Alberti S, Gladfelter A, Mittag T. Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates. Cell. 2019;176. doi: 10.1016/j.cell.2018.12.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Resendes KK, Rasala BA, Forbes DJ. Centrin 2 Localizes to the Vertebrate Nuclear Pore and Plays a Role in mRNA and Protein Export. Molecular and Cellular Biology. 2008;28: 1755–1769. doi: 10.1128/MCB.01697-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Nishi R, Okuda Y, Watanabe E, Mori T, Iwai S, Masutani C, et al. Centrin 2 Stimulates Nucleotide Excision Repair by Interacting with Xeroderma Pigmentosum Group C Protein. Mol Cell Biol. 2005;25: 5664–5674. doi: 10.1128/MCB.25.13.5664-5674.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, et al. Compositional Control of Phase-Separated Cellular Bodies. Cell. 2016;166: 651–663. doi: 10.1016/j.cell.2016.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.La Terra S, English CN, Hergert P, McEwen BF, Sluder G, Khodjakov A. The de novo centriole assembly pathway in HeLa cells. J Cell Biol. 2005;168: 713–722. doi: 10.1083/jcb.200411126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Prosser SL, Straatman KR, Fry AM. Molecular Dissection of the Centrosome Overduplication Pathway in S-Phase-Arrested Cells. Molecular and Cellular Biology. 2009;29: 1760–1773. doi: 10.1128/MCB.01124-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Yang C-H, Kasbek C, Majumder S, Yusof AM, Fisk HA. Mps1 Phosphorylation Sites Regulate the Function of Centrin 2 in Centriole Assembly. Molecular Biology of the Cell. 2010;21: 4361–4372. doi: 10.1091/mbc.E10-04-0298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Lukasiewicz KB, Greenwood TM, Negron VC, Bruzek AK, Salisbury JL, Lingle WL. Control of centrin stability by Aurora A. PLoS ONE. 2011. doi: 10.1371/journal.pone.0021291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Brochet M, Billker O. Calcium signalling in malaria parasites. Molecular Microbiology. 2016;100. doi: 10.1111/mmi.13324 [DOI] [PubMed] [Google Scholar]
  • 61.Pandey K, Ferreira PE, Ishikawa T, Nagai T, Kaneko O, Yahata K. Ca2+ monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor. Scientific Reports. 2016;6: 23454. doi: 10.1038/srep23454 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Helassa N, Nugues C, Rajamanoharan D, Burgoyne RD, Haynes LP. A centrosome-localized calcium signal is essential for mammalian cell mitosis. The FASEB Journal. 2019;33: 14602–14610. doi: 10.1096/fj.201901662R [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Wasserman M, Alarcón C, Mendoza PM. Effects of Ca++ depletion on the asexual cell cycle of Plasmodium falciparum. Am J Trop Med Hyg. 1982;31: 711–717. doi: 10.4269/ajtmh.1982.31.711 [DOI] [PubMed] [Google Scholar]
  • 64.Apolis L, Olivas J, Srinivasan P, Kushwaha AK, Desai SA. Multiple genetic loci define Ca++ utilization by bloodstream malaria parasites. BMC Genomics. 2019;20: 47. doi: 10.1186/s12864-018-5418-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Mittag T, Pappu R V. A conceptual framework for understanding phase separation and addressing open questions and challenges. Molecular Cell. 2022;82: 2201–2214. doi: 10.1016/j.molcel.2022.05.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.McSwiggen DT, Mir M, Darzacq X, Tjian R. Evaluating phase separation in live cells: diagnosis, caveats, and functional consequences. Genes & development. 2019;33: 1619–1634. doi: 10.1101/gad.331520.119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Banjade S, Rosen MK. Phase transitions of multivalent proteins can promote clustering of membrane receptors. eLife. 2014;3: e04123. doi: 10.7554/eLife.04123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Morin JA, Wittmann S, Choubey S, Klosin A, Golfier S, Hyman AA, et al. Sequence-dependent surface condensation of a pioneer transcription factor on DNA. Nature Physics. 2022;18: 271–276. doi: 10.1038/s41567-021-01462-2 [DOI] [Google Scholar]
  • 69.Snead WT, Jalihal AP, Gerbich TM, Seim I, Hu Z, Gladfelter AS. Membrane surfaces regulate assembly of ribonucleoprotein condensates. Nat Cell Biol. 2022;24: 461–470. doi: 10.1038/s41556-022-00882-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Wiegand T, Hyman AA. Drops and fibers—how biomolecular condensates and cytoskeletal filaments influence each other. Emerg Top Life Sci. 2020;4: 247–261. doi: 10.1042/ETLS20190174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Tan R, Lam AJ, Tan T, Han J, Nowakowski DW, Vershinin M, et al. Microtubules gate tau condensation to spatially regulate microtubule functions. Nat Cell Biol. 2019;21: 1078–1085. doi: 10.1038/s41556-019-0375-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.von Appen A, LaJoie D, Johnson IE, Trnka MJ, Pick SM, Burlingame AL, et al. LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation. Nature. 2020;582: 115–118. doi: 10.1038/s41586-020-2232-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ramm B, Schumacher D, Harms A, Heermann T, Klos P, Müller F, et al. Biomolecular condensate drives polymerization and bundling of the bacterial tubulin FtsZ to regulate cell division. Nat Commun. 2023;14: 3825. doi: 10.1038/s41467-023-39513-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Rüthnick D, Vitale J, Neuner A, Schiebel E. The N-terminus of Sfi1 and yeast centrin Cdc31 provide the assembly site for a new spindle pole body. Journal of Cell Biology. 2021;220: e202004196–e202004196. doi: 10.1083/jcb.202004196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Li S, Sandercock AM, Conduit P, Robinson CV, Williams RL, Kilmartin JV. Structural role of Sfi1p-centrin filaments in budding yeast spindle pole body duplication. Journal of Cell Biology. 2006;173: 867–877. doi: 10.1083/jcb.200603153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Musacchio A. On the role of phase separation in the biogenesis of membraneless compartments. The EMBO journal. 2022;41: e109952. doi: 10.15252/embj.2021109952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Woodruff JB. The material state of centrosomes: lattice, liquid, or gel? Current Opinion in Structural Biology. 2021;66: 139–147. doi: 10.1016/j.sbi.2020.10.001 [DOI] [PubMed] [Google Scholar]
  • 78.Banani SF, Lee HO, Hyman AA, Rosen MK. Biomolecular condensates: Organizers of cellular biochemistry. Nature Reviews Molecular Cell Biology. 2017. doi: 10.1038/nrm.2017.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Düster R, Kaltheuner IH, Schmitz M, Geyer M. 1,6-Hexanediol, commonly used to dissolve liquid–liquid phase separated condensates, directly impairs kinase and phosphatase activities. Journal of Biological Chemistry. 2021;296. doi: 10.1016/j.jbc.2021.100260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Knuepfer E, Napiorkowska M, Van Ooij C, Holder AA. Generating conditional gene knockouts in Plasmodium—A toolkit to produce stable DiCre recombinase-expressing parasite lines using CRISPR/Cas9. Scientific Reports. 2017. doi: 10.1038/s41598-017-03984-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Collins CR, Das S, Wong EH, Andenmatten N, Stallmach R, Hackett F, et al. Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle. Molecular Microbiology. 2013;88: 687–701. doi: 10.1111/mmi.12206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Birnbaum J, Flemming S, Reichard N, Soares AB, Mesén-Ramírez P, Jonscher E, et al. A genetic system to study Plasmodium falciparum protein function. Nature Methods. 2017;14: 450–456. doi: 10.1038/nmeth.4223 [DOI] [PubMed] [Google Scholar]
  • 83.Mehnert AK, Simon CS, Guizetti J. Immunofluorescence staining protocol for STED nanoscopy of Plasmodium-infected red blood cells. Molecular and Biochemical Parasitology. 2019;229: 47–52. doi: 10.1016/j.molbiopara.2019.02.007 [DOI] [PubMed] [Google Scholar]
  • 84.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nature Methods. 2012;9: 676–682. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Berg S, Kutra D, Kroeger T, Straehle CN, Kausler BX, Haubold C, et al. ilastik: interactive machine learning for (bio)image analysis. Nature Methods. 2019;16. doi: 10.1038/s41592-019-0582-9 [DOI] [PubMed] [Google Scholar]
  • 86.Lutz R, Bujard H. Independent and tight regulation of transcriptional units in escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Research. 1997;25: 1203–10. doi: 10.1093/nar/25.6.1203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Erdos G, Pajkos M, Dosztányi Z. IUPred3: Prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation. Nucleic Acids Research. 2021;49. doi: 10.1093/nar/gkab408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Provencher SW, Gloeckner J. Estimation of globular protein secondary structure from circular dichroism. Biochemistry. 1981;20: 33–37. doi: 10.1021/bi00504a006 [DOI] [PubMed] [Google Scholar]
  • 89.Sreerama N, Woody RW. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set. Analytical Biochemistry. 2000;287: 252–260. doi: 10.1006/abio.2000.4880 [DOI] [PubMed] [Google Scholar]
  • 90.Miles AJ, Ramalli SG, Wallace BA. DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data. Protein Science. 2022;31: 37–46. doi: 10.1002/pro.4153 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Dominique Soldati-Favre

4 Nov 2023

Dear Dr. Guizetti,

Thank you very much for submitting your manuscript "Malaria parasite centrins can assemble by Ca2+-inducible condensation" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board. This manuscript was previously assessed by Reviews Commons, and the reviewers appreciated the attention to an important topic but raised some  concerns. We have opeted to sent  the revision back to the same reviewers.  Based on the reviews, we are likely to accept this manuscript for publication, providing that you address the outstanding major and minor points and modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The revision of this submission has greatly improved it; the issues raised in my initial review have been satisfactorily addressed and I consider that the data in the paper now support the major conclusions drawn in the study. The expanded discussion positions this work in the context of the literature and will allow readers to consider the ramifications of the authors’ findings in several different directions. I think this paper makes a valuable and interesting contribution to centrosome biology.

Reviewer #2: Plasmodium falciparum survival is very much dependent on its ability to efficiently replicate and one important component of the nuclear replication machinery is centrin. Understanding this can help identify novel drug targets against a parasite that is well known to have developed resistance to almost all anti-malarials. The study has extensively characterised centrins in P. falciparum. The authors have described centrin in normally replicating parasites as well as in the case of protein overexpression in vivo, both instances providing important insights on centrin. Although episomally expressed tagged proteins were used due to the difficulty of tagging the endogenous protein, necessary controls were done, further supporting the data being presented here. The study also covered in vitro characterisation of centrin, demonstrating LLFS in the presence of calcium (but not magnesium), and reversed in the presence of EDTA. They have also conducted similar experiments involving centrins from other evolutionarily distant eukaryotes with predicted intrinsic disordered regions. This therefore will be of great interest to a wider audience, and not just in the malaria community or parasitology. Perturbations on the centrin protein (i.e., removal of the N-terminal intrinsic disordered regions, EFh mutation) demonstrated the importance of these protein regions in liquid-liquid phase separation. The authors have provided circular dichroism spectroscopy to ensure that the mutations do not affect the protein’s secondary structure.

Reviewer #3: The authors conducted several experiments and analyses to address the comments raised by the three reviewers of the initial submission. The manuscript is clearly improved as a result. In my opinion, however, a few outstanding issues remain to be clarified before publication could be endorsed, as detailed hereafter.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: (No Response)

Reviewer #2: No major issues

Reviewer #3: Major points

The major remaining outstanding issue pertains to the relevance of these observations to the behavior of PfCen1 and PfCen3 in vivo, an issue highlighted also by Reviewer 1 and to some extent by Reviewer 3 in their assessment of the initial submission. Obviously, the best way to address this would be to endogenously tag PfCen1 or PfCen3, which the authors argue they cannot do (although they did not attempt N-terminal tagging). In the absence of endogenous tagging, could the authors provide cells with plasmids where PfCen1-GFP or PfCen3-GFP are driven by their respective endogenous promoters? Without such experiments, one is left wondering whether ECCAs might simply result from proteins being overexpressed at non-physiological levels. The authors argue that overexpression experiments are by design (“ the overexpression is, however, used intentionally since protein concentration correlates with the phase separation”), but given the very weak correlation in question (see Fig. S8), perhaps overexpression in all cases is well above the levels of endogenous components, which would then bring little understanding to how these proteins function in regular cell physiology. Another way to mitigate this critical concern would be to show that the level of overexpressed PfCen1-GFP or PfCen3-GFP approximates the levels of the corresponding endogenous proteins. Despite the arguments presented by the authors, it is not clear why they could not estimate the extent of overexpression using PfCen1 antibodies, despite the cross-reactivity towards PfCen3. For instance, they could conduct semi-quantitative immunoblot analysis, taking into account that only ~50% of cells are GFP-positive (see Fig. S7), or else perform immunofluorescence analysis. Despite the cross-reactivity with PfCen3, this should allow them to place a lower bound on the extent of overexpression. If variability of expression levels between cells is an issue, these analyses could be conducted following FACS sorting. Moreover, the authors could also envisage conducting semi-quantitative proteomic analysis, should they want to ascertain this question beyond doubt.

One argument the authors use to argue that overexpression does not impact cell physiology is the absence of significant growth phenotype (see response to Reviewer 1: “Further, we found no significant growth phenotype in overexpressing parasites, which indicates that the centriolar plaque is functional.”). However, in response to Reviewer 3, they write that the “parasite lines seem to silence the Cen1-4-GFP expression plasmids readily, which suggests that there might be a growth disadvantage”, mentioning also that they could to assess this with certainty. Taken together, these comments leave me confused regarding whether there is a growth disadvantage or not. Also, if variability in GFP expression levels is an issue to address this with certainty, the authors could sort cells using FACS and analyze the growth of cells as a function of GFP levels. Overall, this point is important to clarify because a growth defect would be indicative of overexpression interfering with cell physiology.

In response to my comment B), the authors argue that Movies S1 and S2 are not meant to demonstrate the presence of biomolecular condensates, and that the focal planes in Movies S3 and S4 have been selected to highlight the hallmarks of LLPS. What I see in Movie S3 is that the few droplet fusion events (e.g. at 9 seconds into the movie) are, in fact, out of focus. From their reply (“… throughout the entire imaged liquid volume…”), I assume that the authors acquired Z stacks, so that they should choose better focal planes to illustrate such fusion events. As for Movie S4, it appears rather to show that droplets do NOT fuse, as many that appear in physical proximity do not coalesce (again, the fact that the focal plane is usually not the best makes it difficult to say for sure), despite PfCen3 being present at 200 microM. This would argue against LLPS occurring in this case. Could it be that PfCen1 and PfCen3 differ in this respect? Also, a key expectation of LLPS is that droplet size should increase over time. Whereas this might be happening with PfCen1 (although it is difficult to say for sure in the absence of quantification), this does not appear to be the case for PfCen3. The important points must be clarified by further analyses.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: I have a couple of minor points to tidy up before final publication.

1. The reference list should be reviewed for typos, omissions, repetitions etc. There are a lot of mistakes- one presumes this is due to the referencing software, but it is important to get this right in the final version.

2. Some minor typos:

Line 156 ‘evolutionarily’

Line 188 (and 435, 446, 447, 456): ‘to condensate’ is not a verb. It should be replaced by ‘to form a condensate’, ‘to demonstrate condensation’, ‘to undergo condensation’ etc.

Line 217 ‘reevaluating our’

Line 244 ‘pFIO where GFP’

Line 257 ‘not dependent on’

Line 469 ‘attributed’

Line 880 ‘n =’ (I presume).

Reviewer #2: 1. Line 217: “When reevaluating <of> our earlier data from the weaker expressing pArl-Cen1/3-GFP parasite lines…”

Remove “of”

2. Line 243: “To exclude that ECCAs only form due to GFP-tagging we designed a version of pFIO were GFP and PfCen1 were separated by a T2A skip peptide (Fig 5H).”

Should have a “+” after pFIO

3. Figure 5H

Promoter in the figure should only show hsp86 (instead of hsp 70 or 86) to represent pFIO+

4. Line 293: “Taken together these observations argue for condensation being part of the mechanism of centrin assembly at the centriolar plaque.”

Remove “a”

5. Line 581, 600, 638, 681, 741 …

Update referencing format

6. Line 674: “ IFA staining against…”

Remove “A”

7. Line 690: <li> Live cells

Change “Life” to “Live”

8. Line 693: “264x264 pixel images were acquired L HC PL APO CS2 63x/1.4 N.A. oil immersion objective was employed with GaAsP detectors, a pinhole of 0.6 airy units, a pixel size of 35.1 nm and z-stack of 7.28 μm at 130 nm intervals.”

Kindly rephrase

9. Standardise use of “6His” vs “6his” vs “6xHis”

10. Figure S3: missing caption/legend for S3E</life></of>

Reviewer #3: Other points

In an important experiment, the authors tested whether overexpression of untagged PfCen1 also yields ECCAs, finding that this is the case in ~50% of cells in the control (DMSO) condition, and ~80% of cells upon rapamycin addition. Why do ~50% of control cells already have ECCAs? Is this is due to leaky expression? If so, why is this not the case with the constructs inducing PfCent1-GFP expression?

In response to comment 7 of my initial review, the authors write that their data do not conflict with the previously reported notion that Centrin is part of a helical inner scaffold, and mention that they have discussed this matter with the corresponding authors of the study in question, who are said to be in agreement with them. This is surprising in light of what is stated in that manuscript (e.g. the abstract states “POC5, POC1B, FAM161A, and Centrin-2 localize to the scaffold structure along the inner wall of the centriole MTTs.”).

The authors write (lines 83-84) that “our experience confirms that tagging of the C-terminus of PfCen1 and 3 is not achievable even using small tags”, they should spell out in some more detail what they tried (e.g. in the Materials and methods section). Otherwise this information is of limited use to the community.

The authors write (lines 121-123) that “the critical saturation concentration for PfCen1-GFP is well within the range of what can be found for in vitro phase separation of other proteins”, referring to the Li et al, 2020 manuscript. However, an exploration of the LLPSDB data base reported in that manuscript does not seem to provide such values. This should be clarified, perhaps by providing a few exemplary values for readers to appreciate this point.

The authors write (lines 286-287) that the fact that the dissolving effect of hexanediol of PfCen1 in vitro was moderate could be attributed to the polar components of the protein . Is this this also the case for PfCen3? Regardless, how do the authors imagine that the postulated impact of such polar components is shielded in vivo?

The authors write (lines 292-293) that “We further detected a disorganization of the mitotic spindles, which seemed longer and less dense.” This is not apparent from the figure panels. The authors should highlight these feature and, to the extent possible, quantify them.

Line 358-359: the authors mention that Centrins are conserved in all eukaryotes analyzed. To my knowledge, there are no Centrins in nematodes such as C. elegans, nor in insects such as Drosophila. The writing should be rectified to reflect this fact.

In the Material and methods (lines 817-821), the authors report how PfCen1 antibodies were raised, but not how they were affinity-purified. This information must be provided, also for better understanding why these antibodies cross-reacts with PfCen3 but not with the other two Centrin proteins.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Decision Letter 1

Dominique Soldati-Favre

13 Dec 2023

Dear Dr. Guizetti,

We are pleased to inform you that your manuscript 'Malaria parasite centrins can assemble by Ca2+-inducible condensation' has been provisionally accepted for publication in PLOS Pathogens.

However there are two outstanding points that  the reviewer recommends to address

1. It should be more explicitly indicated in the text that ECCAs  are form upon vast overexpression (now finally estimated to be ~18x the endogenous levels), and that this impacts parasite fitness.

2.  The authors  responded that centrin is called “caltractin” in worms and flies, but there are no such proteins and, to my knowledge, centrins are indeed lacking in nematodes and insects.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Acceptance letter

Dominique Soldati-Favre

20 Dec 2023

Dear Dr. Guizetti,

We are delighted to inform you that your manuscript, "Malaria parasite centrins can assemble by Ca2+-inducible condensation," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Schematic map of pARL vector used for ectopic expression of tagged centrins.

    The pARL vector contains a hDHFR cassette, conferring resistance to antifolates, and drives expression of a gene or fusion gene of choice from a weakened promoter of the P. falciparum chloroquine resistance transporter (Pfcrt).

    (TIF)

    S2 Fig. Recombinantly produced centrins have full length size.

    (A) Coomassie gels of wild type centrins recombinantly produced in bacteria and purified via their C-terminal 6His tag show slightly lower migration than expected for PfCen2-6His and PfCen-4-6His (B) Mass spectrometry analysis of native proteins, however, confirms full length expression for all wild type centrins except for cleavage of methionine 1 and occasional detection of degradation bands. (C) Coomassie gels of mutant, tagged and tag-free centrin versions confirms proper expression and show expected migration. Non-plasmodium centrins are T. brucei centrin A (Accession number: XP_846945) 22 kDa, C. reinhardtii centrin (Accession number: P05434) 20 kDa, and S. cerevisiae centrin (Cdc31) 19 kDa.

    (TIF)

    S3 Fig. Centrin phase-separation also occurs at lower concentrations and is calcium specific.

    (A) Transmission light images of recombinant PfCen1-6His, PfCen3-6His, and HsCen2-6His centrin protein solutions at 30 μM concentration before, after calcium, and EDTA addition. Proteins were fluorescently labeled via their 6His tag using 300 nM NTA-Atto 550. Time stamps indicate time elapsed between calcium or EDTA addition and image acquisition. Observed droplets are more sparse than in highly concentrated solution but are still dynamic. (B) Turbidity assay using addition of magnesium followed by calcium addition at the same concentration indicates Ca2+ specifically. and not bivalent cations per se, induces centrin LLPS. (C) Testing different PfCen1-6His concentrations reveals saturation concentration to be below 15 μM. (D) Turbidity assay with recombinant PfCen1-GFP at 20 μM. (E) Turbidity assay with recombinant PfCen1-4 after proteolytic cleavage of any protein tag using various concentrations as indicated. Scale bar: 10 μm. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 or MgCl2 to 2 mM and EDTA to 10 mM, 37°C.

    (TIF)

    S4 Fig. Non-reversible condensate fraction of PfCen3 increases over time.

    (A) Turbidity of PfCen3-6His solution with varying time points of EDTA addition after Calcium addition. (B) Turbidity of PfCen1-6His protein solution with highly delayed EDTA addition shows no irreversible fraction. Overall reduction of turbidity could be explained by protein droplets settling down. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C.

    (TIF)

    S5 Fig. Phase-separating centrins contain intrinsic disordered regions in their N-terminus.

    (A) Using the IUpred 3.0 prediction software we identified a higher intrinsic disorder region probability (red line) in centrins undergoing LLPS in vitro. The highest probabilities are found in the N-terminus before the EFh domains. (B) Using Clustal Omega provided by the EMBL European Bioinformatics Institute we created a phylogenetic tree of centrins from multiple highly divergent eukaryotes, for several of which centrin self-assembly has been shown in vitro in this and previous studies (*). Using IUpred 3.0 we determined centrins with an IDR probability above the 0.5 threshold (red) or without increased IDR probability (blue). Centrins analyzed in this study are in bold.

    (TIF)

    S6 Fig. PfCen1 and 3, but not PfCen2 and 4 contribute to co-condensation.

    Turbidity measurements of recombinant centrins at individually subcritical concentrations either independently or as a mixture during addition of calcium followed by EDTA as indicated. All conditions: 50 mM BisTris (pH 7.1) at 37°C.

    (TIF)

    S7 Fig. pFIO constructs enable robust inducible overexpression of PfCen1-GFP in malaria parasites.

    (A) Flow cytometry analysis of multinucleated malaria parasites (stained with SYTO 61 as a DNA marker) expressing PfCen1-GFP using the classical pARL construct only detects a small fraction of GFP-positive cells with a low median fluorescence intensity. (B) Fraction of GFP-positive parasites strongly increases upon induction of pFIO-PfCen1-GFP transfected cells by rapamycin addition. Median GFP fluorescence intensity is much higher than in pARL whereas the hsp86 promoter generates even higher values than the hsp70 promoter fragment.

    (TIF)

    S8 Fig. Overexpression levels of pFIO+_PfCen1-GFP.

    Western blot analysis of purified 3D7-DiCre_pFIO+_PfCen1-GFP late-stage parasites treated with rapamycin or DMSO (control) in the previous cycle. The signal of endogenous centrin (19.6 kDa, 93 AU) and PfCen1-GFP (46.5 kDa, 717 AU) stained with rat anti-PfCen1 was quantified. Corrected for PfCen1-GFP being only present in a subset of the population (43%, n = 662), as quantified via microscopy, an average (induced) cell has an approximate PfCen1:PfCen1-GFP ratio of 1:18. Staining with anti-PfAldolase was employed as a loading control. Anti-GFP staining indicated no cleavage of PfCen1-GFP, with no expression being detected in the DMSO treated populations with either staining. An additional band at ~21 kDa in the anti-PfCen1 staining is likely the result of cross-reactivity with PfCen3 (20.9 kDa).

    (TIF)

    S9 Fig. ECCA appearance correlates with Cen1-GFP expression levels.

    (A) Graph shows total arbitrary GFP fluorescence intensity of cells transfected with pFIO/pFIO+_PfCen1-GFP one asexual cycle after induction, plotted against the fraction of centrin foci, which are ECCAs per centriolar plaque associated centrin foci. Despite the low r-squared value statistical analysis indicate that the slope is significantly not zero (p<0.0001) and therefore positively correlated. (B) as in A but measured for pFIO+_PfCen1-GFP expressing cells. Slope of linear regression is also significantly not zero (p<0.033) as determined by an F-test. Due to the different expression levels different excitation laser settings had to be used for both parasite lines.

    (TIF)

    S10 Fig. Dimensions of the anti-PfCen1 signal at the centriolar plaque in overexpressing parasites.

    Quantification of immunofluorescence signal at the centriolar plaque measured as in Fig 1D–1E using anti-PfCen1 labeling in rapamycin-induced parasites overexpressing PfCen1-GFP vs control. Using t-test with Welch’s correction width (321 vs 324 nm) shows no difference between the conditions while the height of the signal (247 vs 219 nm) was statistically higher in the induced parasites (p = 0.0081).

    (TIF)

    S11 Fig. Centrin signal concentration in foci is constant prior to spindle formation.

    Mean PfCen1-GFP fluorescence intensity by segmented cellular region in induced parasites carrying pFIO+_PfCen1-GFP relative to mitotic spindle formation in time lapse movies. N > 32.

    (TIF)

    S12 Fig. T2A skipping is very efficient in pFIO+_GFP-T2A-PfCen1.

    Western blot analysis of protein extract from rapamycin-induced and control late-stage parasites carrying pFIO+_GFP-T2A-PfCen1 plasmid. Anti-GFP antibody was used for detection and anti-PfAldolase as a loading control. Rapamycin-induced parasite extract shows a clear band at the expected size (arrow) for “skipped” GFP while the band for the “unskipped” product is barely detectable.

    (TIF)

    S13 Fig. Crossreactivity of rat anti-PfCen1 antibody.

    Western blot analysis using newly generated rat anti-PfCen1 antibody. Antibody was tested against total parasite protein extract of late stage wild type NF54 (left lane) and recombinant PfCen1-4-6His proteins (right lanes). Aside some unspecific background the antibody detects a band of the expected size (20 kDa) in parasite extract. Anti-PfCen1 strongly crossreacts with recombinant PfCen3-6His. Two different contrast adjustments of the same blot are shown.

    (TIF)

    S14 Fig. PfCen1 N-terminus is essential but not sufficient for centrin phase separation.

    (A) Turbidity of chimeric centrin fused from disordered N-terminus of PfCen1 and EFh domain containing part of PfCen4 during calcium and EDTA addition to protein solution. (B) Turbidity of chimeric centrin fused from N-terminus of PfCen4 and EFh domain containing part of PfCen1 during calcium and EDTA addition to protein solution. Conditions: 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C.

    (TIF)

    S15 Fig. EFh-dead point mutations have no substantial effect on the secondary structures of PfCentrin1 protein.

    CD spectra of recombinant PfCen1-6His (black) and EFh-dead PfCen1-6His mutant (magenta) protein show no difference. Calculated secondary structure fractions from the CONTIN-LL analysis method of wild type PfCen1 vs mutant PfCen1 yielded 24.7% vs 24.6% helices, 23.0% vs 22.9% strands, 15.8% vs 15.9% turns, and 36.5% vs 36.6% unordered regions, respectively.

    (TIF)

    S1 Table. Primers used in this study.

    All primers used for amplification of the various construct fragments used for molecular cloning as described above are listed here. Homology regions for Gibson Assembly are in lowercase, PCR binding sequences are capitalized. * Kindly provided by Dr. Friedrich Frischknecht.

    (PDF)

    S2 Table. Oligos used in this study.

    Lowercase letters indicate Gibson assembly or ligation overhangs. All listed ds DNA oligos used for molecular cloning were ordered as GeneArt Strings (ThermoFisher).

    (PDF)

    S3 Table. Antibodies used in this study.

    List of antibodies with information of species, final dilution and source with order number. Starred (*) are dilutions for confocal IFAs. For STED microscopy concentration was increased to 1:200.

    (PDF)

    S1 Movie. Some PfCen1-Halo foci display round fluid-like dynamics.

    STED time lapse movie at 1 s time interval of centriolar plaque region of parasites expressing PfCen1-Halo labeled with MaP-SiR-Halo dye (green). DNA stained with SPY505-DNA (blue). Scale bar, 100 nm. Linear bleaching correction was applied using Fiji.

    (AVI)

    S2 Movie. Some PfCen1-Halo foci display stretched fluid-like dynamics.

    STED time lapse movie at 1 s time interval of centriolar plaque region of parasites expressing PfCen1-Halo labeled with MaP-SiR-Halo dye (green). DNA stained with SPY505-DNA (blue). Scale bar, 100 nm. Linear bleaching correction was applied using Fiji.

    (AVI)

    S3 Movie. PfCen1 displays LLPS upon calcium addition in vitro.

    Transmission time lapse imaging of recombinant PfCen1-6His protein solution at 200 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

    (AVI)

    S4 Movie. PfCen3 displays LLPS upon calcium addition in vitro.

    Transmission time lapse imaging of recombinant PfCen3-6His protein solution at 193 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

    (AVI)

    S5 Movie. HsCen2 displays LLPS upon calcium addition in vitro.

    Transmission time lapse imaging of recombinant HsCen2-6His protein solution at 200 μM concentration displays wetting and fusion events rapidly after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

    (AVI)

    S6 Movie. PfCen3 droplets are not fully resolved by EDTA and display more solid-like properties.

    Transmission time lapse imaging of recombinant PfCen3 protein solution at 193 μM concentration after calcium and EDTA addition does not dissolve droplets. Remaining spheres don’t display fusion or wetting anymore. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 37°C. Image dimensions are 50 x 50 μm.

    (AVI)

    S7 Movie. PfCen3 displays LLPS upon calcium addition in vitro at temperatures below 37°C.

    Transmission time lapse imaging of recombinant PfCen3-6His protein solution at 193 μM concentration displays wetting and fusion events rapidly after calcium addition for longer at lower temperatures. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM and EDTA to 10 mM, 32.5°C. Image dimensions are 50 x 50 μm.

    (AVI)

    S8 Movie. Calcium-induced TbCenA droplets are fusogenic.

    Transmission time lapse imaging of recombinant TbCenA-6His protein droplets in solution at 100 μM concentration displays fusion events after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

    (AVI)

    S9 Movie. Calcium-induced ScCdc31 droplets display surface wetting.

    Transmission time lapse imaging of recombinant ScCdc31-6His protein droplets in solution at 200 μM concentration displays surface after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

    (AVI)

    S10 Movie. Calcium-induced CrCen droplets display surface wetting.

    Transmission time lapse imaging of recombinant CrCen-6His protein droplets in solution at 100 μM concentration displays surface after calcium addition. 50 mM BisTris (pH 7.1), addition of CaCl2 to 2 mM, 37°C. Time lapse is 1 second per frame. Image dimensions are 10 x 10 μm.

    (AVI)

    S11 Movie. PfCen1-GFP overexpression causes ECCA formation.

    Live cell spinning disk time lapse movie at 5 min time intervals of parasite overexpressing PfCen1-GFP (green) from pFIO+ labeled with SPY650-Tubulin (magenta) during entry into schizogony at 37°C. Image dimensions are 15 x 15 μm. Left frame only shows PfCen1-GFP signal. Maximum intensity projection.

    (AVI)

    S12 Movie. ECCAs frequently form at centriolar plaques before detaching.

    Short live cell spinning disk time lapse movie at 5 min time interval of schizont parasite overexpressing PfCen1-GFP (green) from pFIO+ labeled with SPY650-Tubulin (magenta) showing detachment of the brightest foci from the spindle. Image dimensions are 15 x 15 μm. Left frame only shows microtubule signal. Maximum intensity projection.

    (AVI)

    Attachment

    Submitted filename: 135945_1_rebuttal_2768313_rzlskq.pdf

    Attachment

    Submitted filename: Response to reviewers.pdf

    Data Availability Statement

    All data is provided in the manuscript or supplemental information. Image analysis macros are deposited on https://github.com/SeverinaKlaus/ImageJ-Macros.


    Articles from PLOS Pathogens are provided here courtesy of PLOS

    RESOURCES